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The ocular surface is the outermost part of the eye that protects the refractive surface and 
enables sharp vision. The primary components of the ocular surface are corneal and con-
junctival epithelia, lacrimal glands, and meibomian glands that are functionally linked as 
one system. Because of its location, the ocular surface is subject to traumatic injuries and 
diseases. Dry eye, due to inadequate tear production or excessive evaporation, is one of the 
most complicated diseases of the ocular surface, whose exact pathogenesis is not yet fully 
understood, and more effective treatments need to be investigated. 
This dissertation will address the development of an in vitro ocular surface system and its 
application in therapeutic discovery. We first investigated a vitrified collagen membrane 
and its ability to support ocular surface epithelium, which also promoted the repopulation 
of goblet cells, a key component in mucin production. Afterwards a more complex ocular 
surface system was established with both conjunctival epithelium and lacrimal glands, the 
essential parts in tear film secretion. The three-dimensional coculture system highly resem-
bles the structure and tear-secretion function of the native environment. This was further 
evaluated as a model for dry eye disease and a platform for therapeutic evaluation. One 
potential therapeutic we had studied is decellularized extracellular matrices (ECM). The 
particulate form was used as an immunomodulator to reduce inflammation and fibrosis on 
the ocular surface and to accelerate tissue regeneration. Model systems built based on en-
gineering principle provide a new approach for drug discovery. This in vitro ocular surface 
system is proved to recapitulate the physiology of both healthy and diseased ocular surface. 
Its potential as a therapeutic screening device is promising and could be further investigated. 
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Chapter 1. Objectives and Significance 
 
 
The ocular surface is the outermost frontier of our eyes, and it is crucial for the vision 
system. It includes corneal and conjunctival epithelia, lacrimal glands, and meibomian 
glands. All components are functionally linked together as one system, and its homeostasis 
is regulated by the nervous, immune and endocrine system as well. Tear film is the secre-
tory product of the ocular surface and is composed of three layers, which are mucin, aque-
ous and lipid layers. Ocular surface and tear film protect the vision system against foreign 
pathogens, provide lubrication to the refractory surface, and also play an important role in 
the immunity of anterior eye during inflammation. 
Because of its location, the ocular surface system is subject to traumatic injuries and mul-
tiple diseases. In case of severe injuries, tissue engineering strategies are necessary for 
optimal wound healing. Dry eye is an immunopathogenic disease, in which one or more 
layers of the tear film are altered, and it is affecting the life quality of millions of people in 
the United States. It is a complicated ocular surface disease, and its exact pathogenesis is 
not yet fully understood. Typical treatments for dry eye are either artificial tear supplement 
for symptom relief or anti-inflammatory reagents for immuno-regulation.  
This dissertation addressed the development of biomaterials and in vitro model systems for 
the ocular surface. In Chapter 2, we reviewed the current available biomaterials for ocular 
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surface wound healing and their features, with an emphasis on vitrified collagen membrane. 
It also included an overview of organ model systems, for the pathogenesis study of diseases 
and for the discovery of new therapeutics. 
Chapter 3 is the investigation of using vitrified collagen membrane for conjunctival recon-
struction. Vitrigel was able to support the growth of conjunctival epithelial and goblet cells 
in vitro. Vitrigel was transplanted on a rabbit model with conjunctival defects, and its abil-
ity in supporting wound healing and preventing fibrosis was evaluated. 
We developed a coculture model for the ocular surface in vitro in Chapter 4. The 3-dimen-
tional model was composed of conjunctival epithelium and lacrimal gland spheroids. Cul-
ture conditions for both type of cells were studied first for phenotypic development and 
protein secretion. Different designs of coculture were compared for optimal performance 
as well. At last, the coculture system was validated as an in vitro dry eye model for thera-
peutic evaluation. 
Extracellular matrix (ECM) scaffolds have been widely used on tissue engineering and 
regenerative medicine. In Chapter 5, particulate ECM particles were used for corneal 
wound healing after lamellar keratectomy. Results from experiments in vitro and in vivo 
have proven that ECM particles have anti-inflammatory properties and could effectively 
reduce scar size and fibrosis. Therefore, ECM materials are promising therapeutics for cor-
neal wound healing, and the immunoregulation of the ocular surface system. 
In summary, this dissertation addressed multiple approaches in the strategic development 
for ocular surface tissue engineering. Novel biomaterials such as vitrigel and ECM were 
explored and optimized for ocular surface application. Animal experiments were conducted 
3	
throughout different studies as preparation for clinical translations in the future. In vitro 
model system for the ocular surface and tear film was investigated as an alternative to 
animal testing for new therapeutic discovery and screening. The relationship between cor-
neal wound healing and the immunomodulation of the ocular surface was also studied. In 
Chapter 6, we also discussed several possible future research directions, to further improve 
the current therapies for ocular surface diseases. Overall, we successfully developed and 
applied unique tissue engineering strategies on the ocular surface and tear film system, 
involving both novel biomaterials scaffolds and organ model system. They enabled us to 
keep moving forward in the study of disease pathology and to accelerate the evaluation of 
potential therapeutics.  
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Chapter 2. Introduction and Background1 
 
 
2.1. THE OCULAR SURFACE 
The eye is the organ that enables us to perceive the world around us. The ocular surface is 
an essential component of the visual system, as it protects the vital parts of the eye and 
provides the appropriate refracting surface for light rays to enter. Ocular surface is com-
posed of the cornea, conjunctiva, lacrimal glands, meibomian glands and other accessory 
glands (1). The eye and the ocular surface are closely related to other organ systems. The 
nervous and endocrine systems control and affect the secretion of multiple glands on the 
ocular surface; immune cells migrate to the conjunctiva during infection and inflammation; 
the vascular system provides the necessary nutrients for the ocular surface, and is respon-
sible for tear fluid metabolism. 
2.1.1. The structure and transparency of cornea 
Corneal diseases and injuries account for about 80% of blindness worldwide. Besides me-
chanical supports, the cornea also provides about two thirds of the eye’s refraction power 
(2), and this function is guaranteed by the highly organized structure within all layers of 
																																																						
1 This chapter contains material modified from the following article, previously published as: 
Q Lu, O Al-Sheikh, JH Elisseeff and MP Grant (2015). Biomaterials and tissue engineering strategies for 
conjunctival reconstruction and dry eye treatment. Middle East African journal of ophthalmology 22 
(4), 428 
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the cornea. There are five distinct layers in the human cornea: the epithelium, Bowman’s 
layer, the stroma, Descemet's membrane and the endothelium. 
The collagen-rich stroma comprises about 90% of the thickness of the whole cornea. At 
microscopic level, the collagen fibrils are strictly aligned within each lamella, and there are 
about 200 lamellae across the human cornea, stacked together in alternating orthogonal 
directions (3). Corneal transparency mainly depends on two important factors: the uni-
formity of fibril diameter and the distance between adjacent collagen fibrils, and the latter 
is controlled by small leucine-rich proteoglycans, such as decorin, lumicana and keratocan. 
Other layers of the cornea are relatively thin compared to the stroma, but they also affect 
the overall transparency. The epithelium and endothelium serve as barriers for the stroma 
and they play an important role in maintaining the homeostasis of the whole cornea. 
2.1.2. The conjunctiva and goblet cells 
The conjunctiva starts at the corneoscleral limbus, and it covers the sclera and lines the 
inside of eyelids (bulbar and palpebral conjunctiva, respectively), and is connected by the 
fornix. The conjunctiva is composed of a layer of epithelium lying on top of a basement 
membrane, and is the main source of mucins in the tear film. It enables the free movement 
of the eye, provides immune surveillance and secretes mucins into the tear fluid (1). 
The conjunctiva contains a stratified, squamous and non-keratinized epithelium, similar to 
corneal epithelium. Goblet cells are glandular cells residing on conjunctival epithelium, 
that synthesize and secrete the majority of large gel-forming mucins (mucin 5AC) to the 
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ocular surface. Many membrane-bond mucins have been identified on conjunctival epithe-
lium as well, including mucin 1, 4 and 16, and together with the corneal membrane-bond 
mucins, they comprise the glycocalyx on the ocular surface (4). 
2.1.3. The structure of lacrimal gland and its function 
Human lacrimal glands contain both the main glands and the accessory glands. The main 
lacrimal glands contain the palpebral and orbital lobes about 3-5 mm in size. The lacrimal 
gland is an exocrine gland, similar to mammary and salivary glands, and it is comprised of 
many lobules separated from one another by loose connective tissue. The connective tissue 
contains interlobular ducts, vessels, nerve fibers, fibroblasts, many plasma cells, and a few 
lymphocytes (5, 6). 
The interlobular ducts are open to the fornix of conjunctiva, and can be blocked by dam-
aged epithelia during diseased states, thus healthy ocular surface epithelia are crucial for 
maintaining a normal of lacrimal secretion (6). Meanwhile, lacrimal glands secrete the 
aqueous tear fluid containing many ingradients to the ocular surface, and keep the ocular 
surface hydrated and unsusceptible to the infection of pathogens, including antibodies, cy-
totoxic agents, and growth factors and electrolytes (5). 
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2.2. BIOMATERIALS FOR OCULAR SURFACE RECONSTRUCTION 
2.2.1. Injuries and diseases of the ocular surface 
As the front cover for the eye, the ocular surface supports several of the eye’s major func-
tions, as it is composed of highly specialized cells and matrices. At the same time, the 
ocular surface is susceptible to many injuries and diseases.  It can spontaneously begin 
wound healing upon injury, however, severe injuries to the ocular surface, such as chemical 
or thermal burns, Stevens-Johnson syndrome (SJS), and cicatricial pemphigoid post a great 
clinical challenge, especially when the stem cell populations in the cornea are affected. 
Therefore, tissue engineering strategies are necessary for optimal reconstruction of a 
healthy ocular surface without complications, such as fibrosis and wound contracture (7, 
8). The ideal material for ocular surface reconstruction should be a stable, thin and elastic 
membrane, biocompatible with the human body (9). Here we summarize the major mate-
rials that have shown significant promise in either animal models or clinical trials. 
2.2.2. Autologous Tissue Grafts 
An autograft is a piece of tissue harvested from a healthy site in the same patient and trans-
planted to the damaged site to promote healing. As it is from the same individual, an auto-
graft is the safest tissue product that can be used. In conjunctival reconstruction, autologous 
tissues are either conjunctival or non-conjunctival mucous membranes. A conjunctival 
graft from the same or contralateral eye is often applied following the excision of a pter-
ygium, tumor, scar tissue or other lesions. As the graft is usually small, the donor site is 
often left to heal spontaneously, or can be closed with a local flap (8-10). Studies have 
shown that conjunctival defects replaced with healthy conjunctival autografts have less 
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wound contracture and lower risk of disease recurrence. An early study by Tan et al. found 
that donor conjunctival grafting reduced the recurrence rate of pterygium to less than 5%, 
compared to tissue excision alone, which had a recurrence rate of 60% (11). Although this 
procedure is effective, there are several drawbacks. First, autograft transplantation is lim-
ited to unilateral injury, as normal conjunctiva should exist in at least one eye to serve as 
the donor site. Therefore, autologous conjunctival transplantation is impossible in bilateral 
chemical/thermal burns or systemic ocular surface diseases. Other concerns with this pro-
cedure include postoperative discomfort and donor site morbidity, such as fibrosis (10). 
To overcome the limitations of autologous conjunctival grafts, mucous membranes from 
other areas in the patient have been developed as replacements. Oral and nasal mucosas are 
common alternatives when healthy conjunctiva is not available. Oral mucosas harvested 
from different places in the mouth have variable properties. Grafts from the hard palate are 
the thickest and, thus, contract the least, but they are difficult to obtain compared to grafts 
from the buccal or labial regions (12). Researchers have also expanded mucosal epithelial 
cells on oral mucosal graft for treatment of complete limbal stem cell deficiency. This pro-
cedure is called, “cultured oral mucosal epithelial transplantation (COMET)” (9, 13, 14). 
However, unlike nasal mucosa, an oral mucosal graft does not contain goblet cells; there-
fore, it is less satisfactory in situations of extreme dry eye with mucous and goblet cell 
deficiency, such as Sjögren’s syndrome (9). 
2.2.3. Amniotic Membrane 
Human amniotic membrane (AM) is a tissue product harvested from the inner layer of the 
placenta. It is composed of a single layer of epithelium, a thick basement membrane and 
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the underlying avascular stroma (15). Currently, AM is the most widely accepted conjunc-
tival substitute (8). In the 1940s, a fetal membrane containing both amnion and chorion 
was transplanted for conjunctival reconstruction, but the success rate was low as a result 
of live cell inclusion (16). In 1997, the U.S. Food and Drug Administration (FDA) pro-
duced guidelines and surgical standards on the procurement, processing and distribution of 
a tissue product, such as AM. Subsequently, various applications of AM have been reported 
in the literature yearly. Similar to autologous grafts, allogeneic AM can be used as a re-
placement for damaged conjunctival stromal tissue. For example, Acelagraft™ (Celgene 
Corp., Summit, NJ, USA) is a denuded AM that has been lyophilized and sterilized with γ-
irradiation. Moreover, AM can also be used as a preventive patch/dressing for the ocular 
surface to reduce inflammation, scarring and neovascularization, such as Prokera® (Bio-
Tissue®, Doral, FL, USA), where AM is attached to a soft contact lens-sized conformer. 
The beneficial effect of AM could also be utilized as an extracellular matrix (ECM) extract. 
The product, AMX (Amniotic Membrane eXtract, Dr. Emiliano Ghinelli, Verona, Italy), 
is available in Europe for topical applications (17). 
The resemblance between AM and conjunctiva in the composition of basement membranes 
makes AM a successful substitute for the treatment of various ocular surface conditions, 
including chemical or thermal burns, conjunctival tumors or recurrent pterygia (9, 18). 
When processed properly and preserved, AM could promote rapid epithelialization, reduce 
inflammation and vascularization, and suppress fibrosis and pain (15). An analysis of the 
composition of AM ECM extract indicated that the anti-inflammatory action of AM is due 
to the presence of interleukin-10 (IL-10). Additionally, AM supports nerve growth, which 
explains the near scarless healing after AM transplantation (19). 
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Although AM and related products hold great potential in ophthalmic applications, the 
availability, cost and standardization of AM preparation remain problematic. In general, 
the variable composition and properties of AM, reflecting donor differences and non-stand-
ardized preparation, could influence transplantation and result in inconsistent outcomes. 
Additionally, the mechanism of AM’s beneficial actions and its precise molecular compo-
sition require extensive studies (20). Most importantly, as AM is an allogeneic tissue prod-
uct, donor-associated risk of infectious transmission cannot be completely eliminated be-
cause only limited disease screening tests are performed prior to harvesting AM (21). The 
optimal method for processing AM without compromising the therapeutic value is the topic 
of intense research (17). 
Table 2.1. Comparison of different tissue graft materials for conjunctival reconstruction. 
(Adapted and modified from Mai and Bertelmann (12)with permission from Karger Publishers) 
Graft material Oral mucosa Nasal mucosa Amniotic membrane 
Stability high high low 
Thickness thick thick thin 
Color pink pink colorless 
Transparency opaque opaque transparent 
Goblet cell replacement no yes no 
Easy accessibility yes no yes 
Has epithelial stem cells yes yes no 
 
Numerous characteristics require evaluation for the selection of the type of tissue grafts for 
conjunctival reconstruction. For example, injuries in the fornix require the graft to contract 
less than a graft in the bulbar conjunctiva. In extreme dry eye, nasal mucosa is superior to 
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oral mucosa and AM, because it contains goblet cells (12). The features of each tissue graft 
material are summarized in Table 2.1. 
2.2.4. Biomacromolecular Materials 
Since autologous/allogeneic graft transplantations have numerous limitations, advances in 
ophthalmic tissue engineering techniques have led scientists to develop new biomaterial 
matrices. Biomaterials engineered in a laboratory based on macromolecules, such as syn-
thetic polymers and proteins, could have better properties for healing ocular diseases and 
injuries than traditional autologous/allogeneic tissue grafts. First, bioengineered macromo-
lecular materials are tunable, in that their properties can be designed precisely to accom-
modate different requirements. For example, the degradation rate of poly(lactide-co-gly-
colide) (PLGA) can be changed by varying the ratio of lactide to glycolide. Furthermore, 
these biomaterials have much more consistent qualities, and their compositions have been 
extensively studied. Hence these biomaterials present a lower risk for translational use. 
Some biomaterials can be modified to have different functional groups or motifs to selec-
tively promote the growth of a certain type of cells, and drug-loaded particles can be em-
bedded in the materials for controlled release. Due to these advantages, biomacromolecular 
materials are a very promising alternative to tissue grafts for ocular surface reconstruction. 
Although there is a significant body of literature on many biomaterials for conjunctival 
reconstruction, with some positive and promising results, none of the existing materials 
meet all criteria for an optimal substrate for conjunctival repair. The degradable polymer 
matrices PLGA (22) and poly(e-caprolactone) (PCL) (23) were tested in vitro and on ani-
mal models as candidates for conjunctival reconstruction. Lee et al. developed a porous 
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PLGA matrix using a solvent-casting particulate-leaching method that was also modified 
with collagen, hyaluronic acid (HA) and human AM components. The modified PLGA 
matrix showed increased cell adhesion and growth in vitro. In a rabbit model of conjuncti-
val injury, a PLGA graft significantly prevented conjunctival contracture and stromal scar-
ring (22). However, due to the preparation process, the PLGA matrix was neither elastic 
nor transparent. Ang et al. prepared ultrathin PCL membranes by solvent-casting and bi-
axial stretching. The material formed was highly flexible and promoted the attachment and 
proliferation of conjunctival epithelial cells in vitro (23). However, it has not been tested 
on an animal model of ocular injury, and it may be difficult to integrate into the host tissue, 
and there may be induced scar formation due to its aligned fibrillar structure. 
Natural protein molecules, such as collagen (24) and keratin (25), were also tested in ani-
mal models for conjunctival regeneration. Similar to the PLGA graft, the porous collagen-
glycosaminoglycan matrix prevented scar formation in a rabbit conjunctival injury model 
(24). The disadvantage of this matrix is that it not elastic or transparent. Keratin film has 
good mechanical properties including elasticity and transparency, and it is very tunable 
depending on the preparation process (25). However, it may still be too stiff for ocular 
surface use, and the phenotypic development of epithelial cells on a keratin substrate re-
mains unknown, as keratin is not a natural component of conjunctiva.  
2.2.5. Collagen Vitrigel 
Type I collagen is the most abundant component in the ECM of the conjunctival stroma; 
therefore, it is one of the top choices for biomaterial engineers when designing substrates 
for the ocular surface. However, the applications are limited, because collagen hydrogels 
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are opaque and composed of loosely packed collagen fibrils, while the collagen fibrils in 
native conjunctival stroma are highly condensed and well organized (14). To improve the 
properties of collagen hydrogels, Takezawa et al. developed a type I collagen hydrogel 
membrane using a three-step processing method: gelation, vitrification and rehydration (26, 
27). Vitrification is a unique step that allows water in a hydrogel to evaporate in a con-
trolled manner, during which, collagen fibrils reorganize and form crosslinks between each 
other (Figure 2.1A, B). Hence, a normal opaque collagen hydrogel is transformed into a 
thin, elastic and transparent membrane, and, most importantly, its fibril density increases 
tremendously. This material is called “vitrigel” (Figure 2.1C). Beginning with the original 
recipe, our group has studied collagen vitrigel extensively for optimization in ocular sur-
face applications. 
Electron microscopy revealed that the nanoscalestructure of vitrigel is a network of ran-
domly aligned collagen fibrils (Figure 2.1D). There are three variables in the vitrification 
process: temperature, relative humidity (RH) and time. Calderón-Colón et al. systemati-
cally varied these variables and studied the properties of vitrigel under each condition to 
optimize the manufacturing process. Optical, mechanical and thermal properties were 
measured and compared, as they are most relevant for ocular surface application. Conclu-
sively, vitrification occurring at 40 °C and 40% RH for a week yields the optimal vitrigel 
that is highly transparent, mechanically strong and elastic, and denatures at a temperature 
well above the core body temperature of humans (28, 29). As cell proliferation and differ-
entiation largely depend upon the surrounding environment, Guo et al. studied the influ-
ence of nanostructure on cell morphology and phenotype by making vitrigels from different 
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vitrification conditions (30). Although fibrillar density increased with increasing tempera-
ture and time, fibrillar diameter remained constant in all mature vitrigels. The biological 
effect was investigated by growing corneal keratocytes on different vitrigels. Due to the 
difference in nanoarchitecture (fibrillar density, bending, etc.), keratocytes developed dis-
tinct morphologies (30). The optimal vitrigel was able to maintain the native characteristics 
of keratocytes under in vitro conditions (30). Vitrigel is an effective substrate for corneal 
keratocytes, it was successfully used in the reconstruction of corneal epithelium and endo-




Figure 2.1. The preparation of collagen vitrigel and its appearance and structure. 
(A) Three-step preparation. (B) Crosslinking between collagen fibrils occurs during the vitrification 
process. (C) The final vitrigel is a transparent and thin membrane. (D) Transmission electron mi-
croscopy reveals the nanostructure of the vitrigel – the presence of densely and randomly packed 
collagen fibrils (adapted and modified from Guo et al. (30) and Calderón-Colón et al. (28) with 










2.3. TEAR FILM AND DRY EYE DISEASE 
2.3.1. Tear film structure and components 
The tear film, secretion products of the ocular surface, is fundamental for maintaining the 
smoothness and homeostasis of the ocular surface. The components of the tear film include 
a lipid layer and an aqueous layer with soluble mucins, which are mainly secreted by the 
meibomian glands, lacrimal gland and conjunctival goblet cells, respectively. 
2.3.2. Dry eye disease and treatment 
Dry eye represents a major ocular surface disease. According to the 2007 report of the 
International Dry Eye WorkShop (DEWS), dry eye is a multifactorial disease and the 
symptoms include eye discomfort, visual disturbance, tear instability and, potentially, oc-
ular surface damage (32). Based on data from previous studies of dry eye epidemiology, 
about 4.91 million Americans above 50 years of age suffer from dry eye disease. Addition-
ally there are tens of millions more people with less severe symptoms that can be triggered 
through contact with adverse factors, such as contact lens wear or extended use of visual 
display terminals (33). In general, dry eye may have a substantial impact on a patient’s 
quality of life. In patients with severe dry eye, the disease affects even common activities, 
such as driving and reading. Dry eye can be either aqueous-deficient or evaporative, which 
results from problems with the aqueous or lipid layer of the tear film, respectively. Dry eye 
is further categorized into different subtypes, depending on the primary cause (32). Alt-
hough goblet cell dysfunction is not a major cause, most dry eye patients have a signifi-
cantly decreased number of goblet cells. Lack of mucin will further disturb the already sub-
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optimal tear film and ocular surface, increasing the severity of dry eye. Hence, while de-
veloping treatment for dry eye, goblet cell repopulation should also be considered. 
The most common management for mild-to-moderate dry eye is tear supplementation. Ar-
tificial tears, ointments and gels are examples of lubricants that protect the ocular surface 
and treat dry eye. However, some ingredients, especially the preservatives in these products, 
may damage the ocular surface epithelium if used long term. In patients with severe dry 
eye, surgical procedures, such as gland transplantation is necessary to restore a healthy 
ocular surface and tear film. Over the past two decades, research has focused on evaluating 
the pathology of dry eye and developing models for in vitro and animal studies (34). Instead 
of simply hydrating the eye, future therapies will shift to strategies stimulating natural tear 
secretion to maintain ocular surface homeostasis, reducing inflammation and inhibiting ad-
verse effects (32). A robust in vitro model for normal human ocular surface and dry eye is 
also needed for drug screening purposes and pathophysiology studies. 
 
2.4. IN VITRO MODEL SYSTEMS 
2.4.1. Biomimetic “organ-on-a-chip” models 
An organ-on-a-chip is a bioengineered microdevice with living cells, and it usually em-
ploys microfabrication and microfluidics technologies. It mimics the vital functions of the 
living organ and recapitulates organ-level pathophysiology in vitro (35). Organs-on-chips 
have great potential for studying the physiology of normal or diseased organs (36). The 
organ-on-a-chip technique emerged as a cell culture model to replace some costly and time-
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consuming animal studies in the pharmaceutical industry. Regular two- or three-dimen-
sional cell culture was not completely successful because tissue development depends on 
both the architecture of the ECM and its mechanical/structural features (37). Due to the 
small size, the chip system can be used as a high-throughput drug-screening device, and it 
also has therapeutic potential. Theoretically, it could be engineered from dissected tissue, 
primary cells or induced pluripotent stem cells (38). Over the past few years, several organ 
systems have been created on a chip device. A “lung on a chip” was created by apposing 
two poly(dimethylsiloxane) (PDMS) channels separated by a thin, porous and flexible 
membrane. Human alveolar epithelial cells and pulmonary microvascular endothelial cells 
were cultured on opposite sides of the membrane. In the final product, air was introduced 
into the epithelial compartment to create an air-liquid interface and, together with the two 
vacuum chambers on each side, the microdevice was able to manipulate fluid flow and 
membrane stretching, as well as nutrient delivery (37). Liver, gut and spleen organs-on-
chips systems have also been developed (39-41). Recently, bone marrow-on-a-chip, com-
posed of artificial bone and living marrow, was first generated in mice and then maintained 
in vitro within a microfluidic device (42). 
2.4.2. Current ocular model systems 
Thus, such organs-on-chips may have specific use in treating complex ocular diseases. For 
example, dry eye is a complicated disease affecting all parts in the ocular surface. Currently 
dry eye therapeutics is tested in animal models before proceeding to clinical trials. How-
ever, the pathophysiology of dry eye has very different mechanisms in humans and in other 
species. The normal composition of tear fluid also varies among different species. Oph-
thalmic pharmaceutical companies are developing in vitro corneal epithelial models to 
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evaluate the safety and efficacy of novel tear substitutes/lubricants. In vitro models of con-
junctival epithelium and artificial lacrimal glands have also been investigated in the labor-
atory (43, 44). However, these models contained only a single cell type, and they could not 
be maintained for an adequate duration in vitro for physiological study. Hence, for future 
dry eye studies and drug development, it is critical to have an in vitro model that recapitu-
lates the normal or diseased state of the human ocular surface. The combination of multiple 
cell types, such as conjunctival epithelium and lacrimal gland acinar cells, and microfluidic 
channels, will create a model of an aqueous tear-secreting unit. Although some difficulties 
exist, such as the necessary biological and mechanical cues for the construction of chips, 
advances in gene regulation and protein expression of the ocular surface have shed light on 
a potential design for “ocular surface-on-a-chip” for the study of dry eye. For example, 
these chips can be constructed with genetically modified cells to recreate a disease-state 
organ. Marko et al. discovered that a single gene knockout in a mouse model (SPDEF-/-) 
resulted in complete goblet cell loss and moderate dry eye, which is very similar to 
Sjögren’s syndrome (45). Therefore, it would appear that ocular chips made from SPDEF-
/- cells could serve as a comprehensive in vitro model for Sjögren’s syndrome. Furthermore, 
linking a dry eye disease chip with a multi-organ microfluidic device that connects more 
than one single organ chip, such as chips reproducing the immune and vascular systems, 




The ocular surface is the external protective component of the eye, and the conjunctiva 
plays an important role in this protective system. Researchers have been successful in de-
veloping tissue- and biomolecule-based grafts to reconstruct conjunctiva. However, im-
provement is required to render the available biomaterials more consistent, available and 
biocompatible. Dry eye, which can be a serious ocular surface disease, affects tens of mil-
lions of people worldwide. While traditional treatment has major obstacles, breakthroughs 
in organ-on-a-chip technology offer new directions in establishing in vitro models of the 
ocular surface for dry eye disease research. 
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Chapter 3. Vitrified Collagen-Based Conjunctival Equivalent for Ocu-




The primary function of the ocular surface system is to protect the refractive surface on the 
eye. It is composed of continuous epithelia, including the cornea and conjunctiva, and in-
jury to one part may result in system-wide secondary dysfunction (34). The conjunctiva, 
starting from the corneoscleral limbus and lining the inner surface of the eyelids, is a very 
important component of the ocular surface. It is a natural mechanical barrier against path-
ogens, and its main functions include maintaining the equilibrium of the tear film by se-
creting mucins (8, 9). Therefore, conjunctival repair is the prerequisite for successful ocular 
surface reconstruction. The conjunctiva consists of a stratified non-keratinized epithelium 
with goblet cells resting on a basement membrane, and has the capacity to spontaneously 
re-epithelialize upon injury (10). However this is usually accompanied with a certain 
amount of fibrosis and wound contracture, especially in extensive disorders, such as cica-
tricial pemphigoid, Stevens-Johnson syndrome and chemical/thermal burns (9). In these 
																																																						
2 This chapter contains material modified from the following article, previously published as: 
H Zhou*, Q Lu*, Q Guo, J Chae, X Fan, JH Elisseeff and MP Grant (2014). Vitrified collagen-based con-
junctival equivalent for ocular surface reconstruction. Biomaterials 35 (26), 7398-7406. (*equal contribu-
tion) 
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cases, an appropriate tissue substitute needs to be applied for optimal wound healing after 
the excision of diseased tissue. 
The general principle of tissue engineering is to replace tissue lost from disease or trauma 
using biomaterial scaffolds, in combination with cells and/or biological cues to accelerate 
the regeneration (46). The ideal conjunctival substitute should be a stable, thin and elastic 
matrix that is not rejected by the patient’s immune system (9). Although use of autologous 
tissue substitutes (conjunctiva and oral/nasal mucosa) have made progress in clinical stud-
ies (8), and synthetic matrices based on fibrin (47, 48), keratin (25), collagen (24) and poly 
(lactide-co-glycolide) (PLGA) (22) were also tested in animal models, they are limited for 
numerous reasons. For example, available donor grafts are very limited in patients suffer-
ing from systemic autoimmune diseases. Donor site morbidity could be a concern if large 
grafts are required. Furthermore, none of the synthetic matrices is sufficiently elastic for 
ideal conjunctival reconstruction. So far, the most widely accepted substitute is human am-
niotic membrane (AM) (8). AM is epithelium harvested from the inner layer of human 
placenta and contains a basement membrane with underlying stroma. Clinically, AM-based 
conjunctival equivalents have been transplanted to treat ocular diseases with promising 
results. However, the availability, cost and standardization in the preparation of AM still 
remain issues. Therefore, there is a need for a biomaterial scaffold with well-defined com-
position and tunable structure that has excellent mechanical and biological properties for 
ocular surface application. 
Type I collagen is the most abundant component in the extracellular matrix (ECM) of con-
junctival stroma, where collagen fibrils synthesized by fibroblasts form a random network. 
Vitrified collagen (collagen vitrigel, CV) is a vitrified type I collagen membrane and has 
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densely packed and randomly aligned collagen fibrils (26). It is transformed from a normal 
collagen gel (CG) through a vitrification process to become a thin, elastic and transparent 
membrane, and, most importantly, its fibril density is tremendously increased, which has 
been proven to be a significant factor in maintaining cell phenotypes (30). The vitrification 
process has been optimized by systematically varying the conditions (temperature, humid-
ity and time) to yield the best CV that is highly transparent, mechanically strong and elastic, 
and also has a denaturing temperature well above body temperature (28). In vitro, CV has 
been used for the cultivation of various ocular cells, including corneal epithelial cells, with-
out the use of a feeder layer or other substrates (31). In summary, CV was designed for 
ocular surface application with well-defined composition and controllable structure, and it 
closely imitates the architecture and properties of native conjunctival stroma. Therefore, 
we considered utilizing CV as a tissue substitute for cell transplantation in conjunctival 
reconstruction. 
In this study, we attempted to employ the optimized CV to engineer a conjunctival equiv-
alent containing goblet cells, a distinctive phenotype of conjunctival epithelium responsi-
ble for the secretion of large gel-forming mucins in the tear film. The presence of goblet 
cells is an essential indication of a functional conjunctival epithelium, as destruction to the 
conjunctiva could result in decreased numbers of goblet cells. If left uncorrected, this defect 
may cause severe dysfunction of the ocular surface or even blindness (8). Rabbit conjunc-
tival epithelial cells (rCjECs) were isolated and grown on optimized CV, normal CG (with-
out the vitrification process) or tissue culture plates (TCP) (control) to determine the best 
culture substrate. Cell morphology, proliferation and phenotypes were inspected and com-
pared among them. Furthermore, CV-based conjunctival equivalents were transplanted to 
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repair conjunctival defects in a rabbit model. The outcomes were evaluated both anatomi-
cally and physiologically. Conjunctival scarring and contraction were assessed and in-
spected histologically; re-epithelialization, cell integration and goblet cell re-population in 
the defect sites were detected by gene expression and immunohistochemistry studies. Over-
all, the feasibility of CV transplantation as a strategy for treating conjunctival defects and 
restoring a balanced, healthy ocular surface post-damage was demonstrated. 
 
3.2. MATERIALS AND METHODS 
At all times in this study, the animals involved were housed and treated in accordance with 
the guidelines in the ARVO Statement for the Use of Animals in Ophthalmic and Visual 
Research and also with the approval of the Animal Care and Use Committee at Johns Hop-
kins University. 
3.2.1. Collagen vitrigel preparation 
The CV membrane was prepared as previously described (26, 28, 31). Briefly, the proce-
dure includes three main stages: gelation, vitrification and rehydration. Preceding these 
steps, acid collagen solution (0.25% v/v, Cosmo Bio, Tokyo, Japan) was prepared in Dul-
becco’s Modified Eagle Medium (DMEM, Life Technologies, Grand Island, NY) with 10% 
fetal bovine serum (FBS, Thermo Scientific, Rockford, IL) and 20 nM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid buffer (HEPES, Life Technologies) on ice. Collagen solu-
tion was then incubated at 37 °C for 2 hours. After complete gelation, the opaque collagen 
gel was vitrified under 40% relative humidity (RH) at 40 °C, resulting in its conversion 
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into a glassy material. After 1 week, the gel membrane was rinsed with phosphate buffered 
saline solution (PBS, Life Technologies) to remove the phenol red pH indicator in DMEM 
solution. Finally, the vitrigel was rehydrated to obtain a regenerated and stable membrane. 
Normal CG was prepared similarly to CV except that it was only kept in the humidifier for 
one day (40% RH, 40 °C) before rehydration. 
3.2.2. Transmission electron microscopy (TEM) 
The fibrillar structures of CV and CG were revealed by TEM, according to our previous 
study (30). In short, samples were fixed in 3% paraformaldehyde (PFA), 1.5% glutaralde-
hyde, 5 mM MgCl2, 5 mM CaCl2, 2.5% sucrose and 0.1% tannic acid in 0.1 M sodium 
cacodylate buffer at pH 7.2 overnight at 4 °C, followed with post-fixation on ice in the dark 
in 1% osmium tetroxide for 1 hour after buffer rinse. The collagen samples were stained 
with 2% aqueous uranyl acetate for 1 hour in the dark and dehydrated in a graded series of 
ethanol before embedding in Eponate 12™ resin (Ted Pella, Inc., Redding, CA), and al-
lowed to polymerize for two to three days at 37 °C before being transferred to 60 °C over-
night. Thin sections (60-90 nm) were cut on the Reichert-Jung Ultracut E ultramicrotome 
(Reichert, Austria) and then placed on naked copper grids, which were again stained with 
2% uranyl acetate in 50% methanol. Images were taken on a Hitachi 7600 TEM (Hitachi, 
Ltd., Tokyo, Japan) at 80 kV. The top view (surface) of the collagen samples was obtained 
and all chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise 
mentioned. 
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3.2.3. Isolation and in vitro culture of rabbit conjunctival epithelial cells 
(rCjECs) 
Cell isolation and culture were performed as previously described (49). Briefly, after sac-
rifice, the conjunctiva was carefully dissected from New Zealand white rabbits, with un-
derlying connective tissue removed. Conjunctiva tissue was finely minced into 1 mm3 
pieces and cultured as explants on tissue culture dishes in serum-free medium, with epithe-
lium side facing up (Figure 3.2A). Sufficient medium was added to cover the bottom of the 
dish so that the tissue would receive nutrients through surface tension. The cells were cul-
tured in keratinocyte-serum-free medium (K-SFM, Life Technologies) supplemented with 
human recombinant epidermal growth factor (EGF, 5 ng/mL) and bovine pituitary extract 
(50 µg/mL) at 37 °C in a 5% CO2 incubator. When reaching confluence, rCjECs were pas-
saged with 0.05% trypsin/EDTA (Life Technologies). For in vitro study, passage one 
rCjECs were seeded on three substrates at a density of 2 × 103 cells/cm2: CV (Figure 3.2D), 
CG (Figure 3.2E) and TCP. Histology and immunostaining were carried out as described 
below when cells reached confluence (about 5 days).  
3.2.4. Cell proliferation, viability and morphology 
The effects of the three substrates on cell attachment and proliferation were determined 
through use of the alamarBlue® test (Life Technologies), which tests for cellular viability 
quantitatively through the presence of cellular respiration. At days 1, 4, 7 and 9 after the 
initial seeding, alamarBlue® was added directly to the culture medium at 10% v/v and in-
cubated for 4 hours. Absorbance was measured spectrophotometrically at 570 and 600 nm 
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using a microplate reader (SpectraMax, Molecular Devices, LLC, Sunnyvale, CA). Prolif-
eration rate (cell number) was calculated as percent reduction of the alamarBlue® dye, per 
manufacturer’s instructions. 
Cell viability on the three substrates was also examined using the LIVE/DEAD Viability 
Kit (Life Technologies), a two-color fluorescent assay based on differential permeability 
of live and dead cells. Live cells (when monolayer cells reached confluence, in about 5 
days) were stained with green fluorescent calcein AM, a cytoplasm stain, and dead cells 
with compromised cell membranes were stained with red fluorescent ethidium homodimer-
2 (EthD-2). A Nikon Eclipse TE200 fluorescent microscope (Nikon Inc., Melville, NY) 
was used to capture the images of the cell staining patterns. 
Morphology of rCjECs grown on the three substrates was viewed by F-actin staining with 
phalloidin. When cells reached confluence, they were fixed with 4% (w/v) PFA, permea-
bilized with 0.5% Triton X-100 (Sigma-Aldrich) and stained with Alexa Fluor-546 phal-
loidin (Life Technologies) for 30 min. Nuclei were counterstained with 1 µg/mL DAPI 
(4',6-diamidino-2-phenylindole dihydrochloride, Life Technologies) for 30 min. The cells 
were imaged using the Nikon Eclipse TE200 fluorescent microscope. 
3.2.5. Reverse transcription and real-time quantitative polymerase chain reac-
tion (RT-qPCR)  
RT-qPCR analysis was used to quantify the level of mRNA transcripts of two representa-
tive genes (ck4 and muc5ac) expressed in rCjECs on the three substrates. Total RNA was 
isolated from conjunctival cells using the MagMAX™ Total RNA Isolation Kits (Life 
Technologies) and cDNA was synthesized using a high capacity reverse transcription kit 
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for RT-PCR (Life Technologies) according to the manufacturer’s protocol. Real-time PCR 
was carried out on the StepOnePlus™ Real-Time PCR System (Life Technologies) using 
SYBR® Green PCR Master Mix (Life Technologies) with designed primers (Table 3.1). 
The relative expression level of all targets was calculated by the ΔΔCT method (50) and 
normalized against the control sample (TCP) with gapdh (glyceraldehyde-3-phosphate de-
hydrogenase) as the reference. 









F (A1) 5’-ATGTATGCCCTTATGTTCG-3’ 
R (B1) 5’- CGAAACTCAGACATCAGCA-3’ 
F (A2) 5’-GAGCACTGTACAGCGATGCT-3’ 





3.2.6. In vivo rabbit conjunctival defect model 
The conjunctival defect model was designed similarly to that used in previous studies (22, 
24). Six female New Zealand white rabbits weighing between 3 and 4 kg were anesthetized 
by intramuscular injection of ketamine (15 mg/kg) and xylazine (5 mg/kg). The eyelids 
were held open during surgery by a speculum, and a surgical microscope was used during 
all procedures. Round conjunctival defects were produced at the 10 o’clock (superior lat-
eral) position at least 2 mm from the limbus on both eyes of each rabbit. A 7.5-mm diameter 
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vacuum trephine (JEDMED Instrument Co., St. Louis, MO) was used to completely re-
move the conjunctival epithelium, substantia propria and Tenon’s capsule down to the level 
of bare sclera (Figure 3.4A). The process was carried out carefully without damaging the 
underlying sclera. Iris scissors were used to remove the remaining tissue if the trephine did 
not completely sever Tenon’s capsule. Slight retraction of the wound edges resulted in a 
final wound diameter of approximately 9-9.5 mm. 
3.2.7. Collagen vitrigel transplantation 
Six female rabbits were divided into 3 groups (4 eyes/group): treated groups – grafted with 
CV only or CV + cells; untreated group – negative control. Passage 1 rCjECs obtained 
from a male rabbit were seeded on CV at a density of 2 × 103 cells/cm2 and allowed to 
grow for 5 days in vitro before transplantation. In the treated groups, the wound was grafted 
with a 10-mm diameter membrane of CV (with or without cells) using uninterrupted su-
tures with 9-0 Vicryl violet monofilament suture on a BV100-3 needle (taper point, Ethicon, 
Somerville, NJ). Defects in the negative control group were left open without grafting. 
Neomycin and polymyxin B sulfates and dexamethasone ophthalmic ointment (Fera Phar-
maceuticals, LLC, Locust Valley, NY) were applied to all groups immediately after sur-
gery and then once daily for 2 weeks post-surgery. The depth of the conjunctival fornix 
above each wound (Figure 3.4A) was measured immediately post-surgery and at post-op-
erative days 14 and 28 using a blunt probe with a scale for measurement. The percentage 
of fornix shortening was calculated as the percent decrease in fornix depth compared to the 
original value (before surgery). Gross images of the defect were taken every week. At the 
end of 4 weeks, animals were euthanized and conjunctival tissues containing the original 
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defect area from treated and untreated groups were dissected for further analysis. Conjunc-
tiva without defect was also taken and used as the positive control. Half of each tissue 
obtained was fixed in 4% PFA and embedded in optimum cutting temperature compound 
(OCT, Sakura Finetek U.S.A., Inc., Torrance, CA) for sectioning (10 µm) on a cryostat 
(Leica Microsystems Inc., Buffalo Grove, IL). The other half of the tissue was homoge-
nized by ultrasound and the total DNA was extracted for further analysis. 
3.2.8. Histology and immunostaining 
Periodic acid-Schiff (PAS) staining was performed on both in vitro and in vivo samples for 
the detection and distribution of mucosubstances. After fixation with 4% PFA, samples 
were stained with a PAS staining kit (Sigma-Aldrich) according to the manufacturer’s man-
ual. Hematoxylin & eosin (H&E) and Masson’s trichrome (MT) staining were performed, 
as previously described (51), on tissue sections to visualize the morphology of the epithe-
lium and collagen fibril alignment. Samples were imaged as above and at least three ran-
domly selected visual fields were viewed. 
Specific antigen expression was visualized in immunostaining experiments. Primary anti-
bodies of cytokeratin 4 (CK4, clone 6B10, Sigma-Aldrich) and MUCIN 5AC (MUC5AC, 
clone 45M1, Abcam, Cambridge, MA) were used to stain both cell and tissue samples. 
Fluorophore conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA) 
were used to visualized the specific antigens. Briefly, after fixation with 4% PFA, samples 
were first permeabilized with 0.5% v/v Triton X-100 in PBS (PBST) for half an hour and 
then blocked with 4% normal goat serum in PBST for another hour at room temperature. 
After washing, primary antibodies were added at a dilution of 1:200 for both CK4 and 
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MUC5AC and incubated at 4 °C overnight. The next day, after extensive washing, second-
ary antibody was added and incubated for 1 hour at room temperature in the dark. Nuclei 
were stained with DAPI for 30 min afterwards. Images were taken either under a fluores-
cent light microscope (Nikon Eclipse TE200) or a confocal microscope (Zeiss LSM 510, 
Carl Zeiss Microscopy, LLC, Thornwood, NY). The percent of positively stained cells for 
each marker was calculated using ImageJ software (US National Institutes of Health, Be-
thesda, MD) and at least 6 random fields per sample were analyzed. 
3.2.9. Statistical Analysis 
Data are shown as mean ± standard deviation (SD). All experiments were performed with 
at least three repeats. Data were analyzed using the two-sample equal variance student’s t-
test. A probability (P) value less than 0.05 was considered statistically significant. 
 
3.3. RESULTS  
3.3.1. Morphology and proliferation of conjunctival epithelial cells 
 
Figure 3.1. rCjEC isolation and culture in vitro. 
(A) Cells started to migrate out of the explant (asterisk) within a day. (B) rCjECs displayed a squa-
mous morphology when reaching confluence after proliferating for 3-5 days. Scale bar: 200 µm. 
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Epithelial cells were isolated and subcultured on three different substrates: CV, CG and 
TCP. The differences in the fibrillar organization and density of CV and CG were shown 
by TEM (Figure 3.2D, E). After the 1-week vitrification, CV showed random fibrillar or-
ganization with a high density of collagen fibrils. In comparison, CG had a much lower 
density of collagen fibrils, which also appeared to be bent (Figure 3.2D, arrowhead). In 
primary explant culture, rCjECs that had migrated from the explant displayed nonkeratin-
ized squamous epithelial morphology and reached confluence within 5 days (Figure 3.1). 
After being passaged, the cells attached and proliferated on the three different substrates. 
As shown by live/dead staining (Figure 3.3A-C), attached cells exhibited very high viabil-
ity (over 95%) regardless of the substrate type. The majority of the cells appeared to be 
nongoblet epithelial cells with a small squamous morphology (Figure 3.3D), while the 
larger cells contained an extensive accumulation of secretory vesicles in the cytoplasm and 





Figure 3.2. Schematic view of experimental design. 
(A) Rabbit conjunctival epithelial cells (rCjECs) isolation and harvest. (B) Cultivation of rCjECs 
on CV with the specific goblet cell phenotype. (C) Reconstruction of conjunctival defect using CV 
based conjunctival equivalent. (D, E) TEM images showing the fibrillar density and organization 
of normal CG and optimal CV, respectively. Arrowhead showing the bending of collagen fibril. 




Figure 3.3. rCjEC morphology and proliferation in vitro. 
(A-C) Live (green)/dead (red) staining of rCjECs grown on different substrates (CV, CG and TCP). 
(D, E) Phalloidin 546 (red, for actin) and DAPI (blue, for nuclei) staining for visualization of rCjEC 
morphology in culture; arrowheads indicated typical squamous epithelial cells (D) and goblet cells 
(E). (F) Proliferation assay of rCjECs cultivated on different substrates; cell number was directly 
proportional to the percent reduction of alamarBlue® dye. Scale bar: 100 µm. 
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The alamarBlue® assay was used to quantify cell proliferation on different growth sub-
strates. The data were plotted as percent reduction of the alamarBlue® dye, which is pro-
portional to cell number (Figure 3.3F). Starting from the same seeding density, one day 
after cell seeding, CV had a greater number of cells grown on it than either CG or TCP, 
indicating rCjECs preferentially attached to CV compared to the other substrates. By day 
9, there were more than twice as many cells grown on the CV substrate than on the TCP 
substrate. The difference between the number of cells grown on CG and TCP substrates 
was also statistically significant. 
3.3.2. Collagen vitrigel maintained the phenotypes of rCjECs in vitro 
Rabbit CjECs grown on the three substrates were tested to determine their conjunctival 
epithelial phenotypes. PAS staining is used to detect mucosubstances (magenta) in cells 
and tissues, and strong staining indicates the presence of mucin-secreting goblet cells. 
More mucins and stronger staining were observed on the CV and CG substrates compared 
to the TCP substrate (Figure 3.4A-C). Non-goblet epithelial cells and goblet cells can be 
identified by the presence of CK4 (Figure 3.4G-I) and MUC5AC (Figure 3.4D-F) respec-
tively. Approximately 13% of the rCjECs grown on CV stained positive for MUC5AC and 
41% stained positive for CK4. The percentages for CG were 8% and 26%, respectively. 
Only 2% (MUC5AC) and 17% (CK4, Figure 3.4J) of cells grown on TCP stained positive, 





Figure 3.4. rCjEC phenotypic analysis in vitro. 
rCjECs were cultured on 3 substrates, CV, CG and TCP. (A-C) Mucins were detected by PAS 
staining (goblet cells were indicated by the arrowhead). (D-I) Immunocytochemistry was per-
formed to visualize conjunctival epithelial specific markers: (D-F) MUC5AC for goblet cells; (G-
I) CK4 for non-goblet epithelium. (J) Percent of positively stained cells in MUC5AC and CK4 
immunostaining, analyzed by ImageJ software. (K) RT-qPCR analysis of the expression of con-




RT-qPCR was also conducted to characterize gene expression of rCjEC cultured on the 
three substrates (Figure 3.4K). Cells grown on CV exhibited a 2.0- and 1.8-fold increase 
in ck4 and muc5ac transcripts in comparison to TCP, respectively. There was no significant 
difference in muc5ac expression of cells grown on CV and CG. However, ck4 expression 
was higher in cells grown on CG than those on CV. 
3.3.3. Reconstruction of conjunctival defect using CV 
We attempted to reconstruct conjunctival defects by transplanting the CV conjunctival 
equivalent in a rabbit model. The 7.5-mm wound involved injury to all three parts (bulbar, 
tarsal and forniceal) of the conjunctiva (Figure 3.5A). The defect was grafted with CV 
(with or without cells, Figure 3.5B) by sutures. Re-epithelialization started at 1 week in all 
groups, including the negative control (Figure 3.5C, F and I). After 2 weeks, the CV mem-
branes turned opaque and began to degrade, but still remained intact on the defects (Figure 
3.5D, G); while there was early sign of wound contracture in the negative control (Figure 
3.5I, J), it was not observed in the two treated groups. By the end of 4 weeks, healing was 
finished in all three groups and the CV membranes were completely degraded in the treated 
groups. The negative control showed obvious conjunctival shortening in the defect area 
(Figure 3.5E, H and K). Furthermore, forniceal length was measured and compared be-
tween groups as a quantitative indication of wound contracture (Figure 3.5L, M). The neg-
ative control group showed significant conjunctival contraction with fornix shortening of 
21.1% at 2 weeks and 35.5% at 4 weeks, respectively. By contrast, neither of the CV treat-





Figure 3.5. Macro-inspection of conjunctival reconstruction using CV in a rabbit model. 
(A) Illustration of the defect model: the superior forniceal depth was measured starting from the 
fornix to the limbus; a close-up look of the defect model with the upper eyelid extended. The defect 
was 7.5 mm in diameter and at least 2 mm from the limbus; all layers above the red dashed line 
were removed. (B) A photo taken right after grafting CV (with alamarBlue® dye) on the conjunc-
tival defect with sutures. (C-K) Gross images showing the progress of conjunctival repair in the 
two treatment groups plus control at various time points. (L) Depth of fornices after surgery at 
various time points in the two treatment groups plus control. (M) Shortening of the fornix (%) after 
introducing the defect. The edges of the defect were outlined by the black dashed line; wound 




3.3.4. Assessment of the repaired conjunctival tissue 
The outcomes of conjunctival defects repaired by CV were evaluated by histological stain-
ing and compared to both positive (no defect) and negative (defect without repairs) controls. 
H&E staining after 4 weeks shows complete re-epithelization (continuous epithelia) in all 
groups (Figure 3.6A-D). The two groups treated with transplanted CV membranes (with 
and without epithelial cells) both showed three-to-seven stratified epithelial layers with 
distinct cuboidal basal cells, very similar to normal conjunctival epithelium. PAS staining 
was used to visualize mucin distribution (Figure 3.6E-H). Strong PAS-positive staining, 
representing conjunctival goblet cells, was found in these stratified epithelial layers, and 
the amount of stained mucins was also comparable to that present in the positive control. 
There were fewer epithelial layers in the negative control and the cells had a flattened mor-
phology with very few of them stained strongly with PAS.  
To further visualize the conjunctival stroma fibrillar organization, MT staining was per-
formed (Figure 3.6I-L). In both treated groups, collagen networks composed of random 
aligned fibrils and loosely packed fibroblasts were found in the reconstructed substantia 
propria, resembling the uninjured normal tissue. In contrast, mature subepithelial fibrous 
scar tissue was identified in the untreated wound by the high density of aligned collagen 





Figure 3.6. Histological analysis of conjunctival defect reconstruction. 
(A-D) H&E staining. (E-H) PAS staining, showing the mucin distribution in the repaired epithelium. Goblet cells are shown by arrowhead. (I-L) 
Masson’s trichrome staining for the visualization of collagen fibrils; scar tissue (asterisk) was observed only in the negative control (NC; PC, positive 
control). Scale bar: 100 µm.
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The presence of goblet cells and the phenotypes of reconstructed epithelium were further 
proven by immunohistochemistry. The staining of CK4, a conjunctival specific cytokeratin, 
suggested a continuous epithelium in all groups (Figure 3.7A-D). MUC5AC staining rec-
ognized the specific secretory conjunctival mucin (5AC subtype), and selectively stained 
goblet cells. Examination of MUC5AC staining in the defect site after transplantation re-
vealed a significant difference in goblet cell percentages (Figure 3.7E-H) among the groups. 
The defect site grafted with CV+cells was densely repopulated by MUC5AC-positive gob-
let cells (23%), comparable to uninjured tissue (30%), and some mucins might have even 
been secreted outside the epithelium. On the contrary, goblet cells were nearly absent (less 




Figure 3.7. Immunohistochemistry analysis of reconstructed conjunctiva. 
(A-D) CK4 staining showing the thickness and continuity of the epithelium. (E-H) MUC5AC staining for goblet cells; the numbers in upper right 
corners are the percent of positively stained cells (MUC5AC positive cells divided by total number of cells in the epithelium). Scale bar: 100 µm. 
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3.3.5. Survival and integration of transplanted cells in the defect 
In our in vivo study, male rabbit cells were intentionally delivered to female hosts, enabling 
us to monitor the transplanted cells with PCR by detecting the sry gene, specific to the Y 
chromosome. Four weeks post-transplantation, the reconstructed conjunctival tissue in the 
CV + cells treated group was dissected and subject to conventional PCR for the detection 
of sry. Nested PCR primers were later designed to further amplify the product and ensure 
specificity (Figure 3.8A). As confirmed by Figure S3.8B, the treated group (CV+cells) was 
positive for the sry gene, as compared to the positive (DNA from male rabbit tissue) and 
negative (DNA from female rabbit tissue) controls. 
 
Figure 3.8. Post-transplantation cell integration in the conjunctival defect, detected by nested 
PCR. 
(A) Design of nested PCR for the detection of the sry gene (male cells): conventional PCR was first 
performed, followed by nested PCR, using 4 primers (A1, A2, B1 and B2). (B) Agarose DNA gel 
confirmed the presence of the sry gene in the CV+cells treated sample (PC – positive control; S – 




The conjunctiva is an important functional and structural component of the ocular surface. 
Conjunctiva-related diseases and injuries will compromise the homeostasis and function-
ality of the ocular surface, and, in severe conditions, tissue-engineering strategies must be 
applied for optimal reconstruction to prevent severe morbidities or even blindness. An ideal 
conjunctival equivalent should meet several criteria: sufficiently elastic and well tolerated 
without causing inflammation or stimulating rejection; it should carry an epithelium with 
the distinctive goblet cell phenotype for better mucin production and secretion, as many 
ocular surface disorders are associated with mucin-deficient dry eye diseases (9). Here, we 
reported the development of a conjunctival equivalent composed of CV and an epithelial 
layer for the treatment of ocular surface disorders involving conjunctival defects. 
Cell differentiation and tissue development largely depend on the surrounding niche. To 
achieve optimal outcomes in the tissue engineering process, the applied biomaterials 
should imitate the properties of the native tissue (46). CV is a type I collagen membrane, 
formed through a three-step procedure (gelation, vitrification and rehydration). Its mechan-
ical and optical properties can be easily controlled by changing the vitrification parameters 
(time, temperature and humidity). Considering ocular surface application, Calderón-Colón 
et al. (2012) found that CV synthesized at 40 °C and 40% RH for one week had the best 
properties, i.e., transmittance of up to 90%, tensile strength up to 12 MPa and a denaturing 
temperature significantly higher than 37 °C (28). On the nanoscale, the vitrification process 
results in a dramatic increase in fibrillar density and stiffness. As a cell culture substrate, it 
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has been shown that the unique nanoarchitecture of CV could maintain the characteristics 
of corneal keratocytes even in serum-based medium (30). In our study, two types of colla-
gen materials were compared: the optimized CV and normal CG to investigate the effect 
of the materials’ nanoarchitecture on the cultivation of conjunctival epithelium. TEM im-
ages (Figure 3.2D, E) revealed significant differences in the organization of collagen fibrils 
between the two materials. With the optimized vitrification process, the collagen fibrils in 
CV were much more densely packed and organized compared to those in CG, although the 
fibrillar diameter and D-periodicity remain unaltered for the two collagen materials (30). 
One of the most important functions of the conjunctiva is mucin production and secretion, 
mainly fulfilled by goblet cells. Therefore, the number and secretory level of goblet cells 
are crucial indications of the epithelium’s functionality. Previously, it was commonly ac-
cepted that conjunctival epithelium cultivated in vitro cannot develop the unique goblet 
cell phenotype, even when cultured on a supporting substrate. For example, when AM was 
used, the epithelium could proliferate, but without goblet cells, despite adding retinoic acid, 
lifting the culture to the air-medium interface or co-culturing with fibroblasts on the stro-
mal side of AM (52, 53). However, our results proved that CV membrane successfully 
supported the growth and phenotypic development of rCjECs, as shown in Figures 2 and 
3, including goblet cells. The epithelium formed on top of CV could express markers of 
both non-goblet epithelial (CK4) and goblet (MUC5AC) cells detected by gene expression 
and immunocytochemical analyses. The CG group also showed an improvement in sup-
porting rCjECs over TCP, but except the transient increase in ck4 mRNA level, the effect 
was not as profound as CV. The beneficial effect of CV in supporting cell culture could be 
attributed to its highly organized and dense fibrillar structure, which closely mimics the 
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extracellular matrix (ECM) in native connective tissue. Our in vitro model justifies the 
feasibility of utilizing CV as a carrier for conjunctival epithelium transplantation.  
Different types of tissue substitutes have been developed and studied as conjunctival equiv-
alents for transplantation. These include autografts from healthy conjunctiva, oral mucous 
membrane and nasal turbinate mucosa, human AM and synthetic materials. The application 
of an autograft is restricted to the regeneration of a small, unilateral conjunctival defect, as 
the size of an available donor site could be very limited and insufficient. Human AM, ini-
tially used to promote wound healing, is the most widely accepted substrate for the repair 
of ocular surface defects and has been reported to be used for reconstruction following 
different conditions, including chemical or thermal burns, conjunctival tumors or recurrent 
pterygia (9, 18). It could promote rapid epithelialization, reduce inflammation and vascu-
larization, and also suppress fibrosis (15). However, certain drawbacks still exist for AM 
transplantation. Generally speaking, the composition of AM may vary because of donor 
differences, which influence clinical results after transplantation; furthermore, the mecha-
nism of its beneficial effect is not extensively studied and well understood (20). In addition, 
there is a donor-associated risk of transmitting infections because only limited disease 
screening tests are performed before AM is harvested. Specifically, although numerous 
AM products are now available for ocular surface application, the preparation procedure is 
not standardized. Researchers are still looking for the optimal processing method for AM 
without affecting its physical and biological properties (17). 
The limitation of AM transplantation and advancements in tissue engineering techniques 
have inspired scientists to develop synthetic and biomaterial matrices for ocular surface 
repair. Synthetic substrates, such as PLGA (22) and poly(e-caprolactone) (PCL) (23), and 
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natural biomolecules, such as collagen (24) and keratin (25), were investigated and tested 
in animal models for conjunctival regeneration. Although positive outcomes were reported, 
none of the existing biomaterials could meet all the criteria of an optimal substrate for 
ocular surface reconstruction. The PLGA and collagen sponges have a randomly porous 
structure favored for cell infiltration and regeneration, but they are neither elastic nor trans-
parent and are not suitable for carrying an epithelial layer. Keratin film has good mechan-
ical properties, but it is too stiff for ocular surface use and the phenotypic development of 
epithelial cells on a keratin substrate remains unknown. PCL membrane was shown to be 
thin and elastic, and a conjunctival equivalent was created in vitro; however, it may be 
difficult to integrate into the host tissue and its aligned fibrillar structure may induce scar 
formation. CV, however, exhibits superior properties over other available biomaterials for 
ocular surface application because of its mature fibrillar structure resulting from controlled 
vitrification. Transparent and elastic CV membrane can be made with customizable dimen-
sions, and is easy to manipulate and fixate with forceps and sutures. In our animal study, 
CV manufactured under optimized conditions was grafted onto the conjunctival defect ei-
ther on its own or as a carrier for epithelial cells. In both cases, CV showed good biocom-
patibility and it was completely degraded at the end of the healing process. 
Many ocular surface diseases involving conjunctiva are accompanied by decreased goblet 
cell number and/or lowered MUC5AC secretion level (8). After severe injuries or surgical 
trauma to the conjunctiva, although re-epithelization usually starts spontaneously, the re-
population of goblet cells cannot happen effectively unless an appropriate graft is applied 
to aid the healing process (22). Our present study shows that there is no significant differ-
ence between CV and CV with cells in promoting wound healing and re-epithelization; 
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both treated groups resulted in intact and stratified conjunctival epithelium within the area 
of the wound. However, evidence from histology and immunohistochemistry assays (Fig-
ures 5 and 6) confirmed that the graft of CV with cells led to the best result and the greatest 
number of re-populated goblet cells. Strong PAS and MUC5AC staining could be observed 
in the reconstructed area only when cells were transplanted together with CV, and the level 
of staining for both was comparable to that of uninjured conjunctiva.  
Furthermore, by detecting the expression of the sry gene (Figure 3.8), we proved that trans-
planted male donor cells survived and integrated into the female host. The absence of gob-
let cells at the defect site in the CV only and negative control groups suggests that in the 
cell treatment group the re-populated goblet cells were primarily derived from transplanted 
cells rather than being of endogenous origin. The CV carrier has protected transplanted 
goblet cells within a hostile defect environment for better survival. Previous attempts at 
reconstruction in different models utilized AM as the epithelium carrier in treating limbal 
stem cell deficiency (54) or conjunctival defect (55); however, neither epithelial equivalent 
could confirm the presence of goblet cells. Thus, here, we demonstrate that CV membrane 
seeded with epithelial cells can help the phenotypic development of goblet cells in vivo 
during conjunctival regeneration. 
Anatomically, the surface area of conjunctiva exceeds the area of contact with the eyeball 
and eyelids. This excess tissue folds in the fornix, the junction of bulbar and tarsal con-
junctiva, ensuring the restriction-free excursion of the eye (10). Biopsy studies also pointed 
out that the fornix has the greatest density of goblet cells (56). During spontaneous wound 
healing, re-epithelialization is followed by formation of a subconjunctival fibrous scar, 
wound contracture and eventually fornix shortening. The fibrous scar occurs as a result of 
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the uniaxial arrangement of newly synthesized collagen fibers by fibroblasts in the wound 
bed, which differs from the random alignment in normal subconjunctival stromal tissue 
(22). The amount of scarring that the conjunctiva undergoes can have severe consequences 
on the movement and function of the eye and may ultimately cause visual impairment (10). 
Grafting of a matrix with randomly aligned fibrils could effectively prevent the formation 
of both aligned ECM fibrils and myofibroblast differentiation, helping to re-establish the 
normal fornix (22, 24). Similarly, transplantation of CV resulted in significant inhibition 
of forniceal shortening (less than 4% shortening for both treated groups). Histologically, a 
loose network of collagen fibrils and fibroblasts in the reconstructed subconjunctival 
stroma resembles that in normal tissue, while the untreated wound has severe sign of fi-
brous tissue, indicated by the condensed, aligned collagen fibrils (Figure 3.6L). 
This study has extended the application of CV further to parts of the ocular surface other 
than the cornea. Previous studies have already demonstrated that CV could be used to ex-
pand numerous types of corneal cells. Therefore, with our results, we can hypothesize that 
CV tissue equivalent could be applied when injuries involve more than one part on the 
ocular surface. Except for the re-population of goblet cells, the difference between CV only 
and CV with cells are not quite significant. The reason could be due to the design of the 
conjunctival defect model, which involves only surgical injury. In this case, re-epitheliza-
tion occurs very rapidly in rabbits. However, in clinical cases, ocular surface injuries often 
are not restricted to one region and are usually associated with other complications, such 
as limbal stem cell deficiency and dry eye diseases. In the latter cases, expansion of har-
vested cells is necessary before transplantation. Therefore, CV with an expanded epithelial 
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cell layer may be more promising in these complex clinical injuries. In the future, the ap-
plication of CV on ocular surface defect models involving more complicated conditions 
should be investigated before clinical studies are carried out. 
 
3.5. CONCLUSIONS 
Our work proves the efficacy of utilizing CV to create a transplantable conjunctival equiv-
alent to repair defects resulting from surgical trauma, severe burns or other injuries or dis-
eases. Unlike previous attempts using other materials, because of the unique collagen fi-
brillar structure of CV, considerable numbers of goblet cells were present on the membrane 
before transplantation and in the reconstructed defect area, as well. We were able to limit 
the amount of contraction and fibrosis scarring to the minimum without compromising the 
re-epithelization process. Therefore, CV holds great potential clinically as a carrier for ep-
ithelial cell transplantation for the reconstruction of ocular surface injuries. 
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The ocular surface is the outermost layer of the eye. Together with the tear film, it protects 
the refractive surface and enables sharp vision (57). This ocular surface and tear film sys-
tem is comprised of corneal and conjunctival epithelia, as well as many tear-secreting 
glands, such as lacrimal and meibomian glands (58). They are functionally linked as one 
system by continuous epithelia, innervation, and the immune system (1). The tear film is 
divided into three layers: mucin, aqueous, and lipids. It lubricates the eye surface, protects 
it against foreign pathogens and infections, and closely interacts with ocular surface epi-
thelial cells through the mucin-aqueous layers (59). The ocular surface and tear film system 
is a highly dynamic structure. The maintenance of its stability is essential to healthy vision. 
Even minor disruptions can result in significant permanent damage to other parts of the 
visual-sensory system (57). 
Dry eye is a common ocular surface disease involving dysfunction of the tear film that 
affects millions of people worldwide, with a significant impact on the quality of life (58) 
																																																						
3 This chapter contains material modified from the following manuscript, previously submitted as: 
Q Lu, H Yin, MP Grant and JH Elisseeff (2017). An In Vitro Model for the Ocular Surface and Tear Film 
System. Scientific Reports under review.	
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Although the exact pathogenesis is not completely understood, it is widely believed that 
the development and progression of dry eye is mediated by cellular inflammatory mole-
cules secreted by the ocular surface immune system (60). When the ocular surface is ex-
posed to environmental stress that causes changes in tear composition, an inflammatory 
cascade is activated in which various cytokines and chemokines are released (61). This 
results in the migration of antigen presenting cells, and subsequently the infiltration of 
helper T cells (subtypes TH1 and TH17) to the ocular surface.  During this time more 
cytokines and chemokines are secreted, and the epithelia are consequently damaged (60, 
61). To learn more about the molecular basis of dry eye, disease pathogenesis study and 
potential therapeutic evaluation have been conducted either in vivo or on simple models in 
vitro (33, 34). 
Tissue models and organ-on-a-chip strategies combine multiple cell types to create minia-
turized versions of physiologically active and functional tissues in the body. Numerous 
organ systems, such as lung, intestine, and bone marrow, have been successfully fabricated 
and utilized in various disease conditions (37, 39, 42). Specifically, a complex disease sys-
tem was induced in a lung-on-a-chip microdevice, leading to the discovery of a potential 
new drug for pulmonary edema (62). Numerous in vitro models have been established in 
the past few years to mimic different parts of the ocular system. Mature retina was gener-
ated from human induced pluripotent stem cells (hiPSCs) with fully functional photore-
ceptors to recapitulate retinal development. This system was applied to model retinal dys-
function, including age-related macular degeneration (63). Coculture of retinal pigment 
epithelium (RPE) and photoreceptors has been attempted to further mimic normal differ-
entiation and morphology (64). Moreover, Chan KY, et al. manufactured a microfluidic 
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chip to study the intraocular emulsification of silicone oil (65). An in vitro corneal model 
was developed on a sacrificial collagen film across microfluidic channels, presenting an 
alternative for the screening of ocular irritants (66). 
Considering the ocular surface and tear film, researchers have been investigating the in 
vitro modeling of several components individually, including conjunctival epithelium (43) 
and lacrimal glands (67, 68). In these models, cell morphology and phenotype resembled 
the equivalent cells in vivo. However, combining these cells types to create a functional 
tear film has not been studied. To address this gap, we developed a complex three-dimen-
sional (3D) in vitro model for the ocular surface. This model contains primary rabbit con-
junctival epithelial cells and lacrimal gland cell spheroids, to recapitulate the aqueous and 
mucin layers of the tear film. We first investigated the culture conditions for both cell types 
to optimize their secretory functions. Next, we combined the two cell types and compared 
several coculture systems to optimize tissue structure and tear secretion. Inflammation was 
induced to mimic dry eye disease in the coculture model system, and its response to thera-
peutics was compared to monoculture. Overall, we engineered a model system for both a 




4.2. MATERIALS AND METHODS 
4.2.1. Primary cell isolation 
Young New Zealand white rabbit tissues (eyes and lacrimal glands) were purchased from 
Pel-Freez Biologicals (Rogers, AR). 
Rabbit conjunctival epithelial cells (CECs) Rabbit eyes with eyelids attached were rinsed 
with DMEM/F12 (Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12; Thermo 
Fisher Scientific, Waltham, MA) with 1% antibiotic-antimycotic solution (Thermo). The 
entire conjunctiva (including bulbar, fornix and palpebral) was dissected 1 mm from the 
glandular edge of the tarsal plate and 2 mm from the limbus, with excessive Tenon's tissue 
trimmed off. The tissue was digested with Dispase® II (1.2 U/mL, Roche Diagnostics, 
Indianapolis, IN) at 4°C overnight. The loosened epithelial aggregates were collected with 
a cell scraper, followed by centrifugation at 200 g for 5 minutes. The cell pellet was treated 
with Accutase® (Sigma-Aldrich, St Louis, MO) for 10 minutes at 37°C and filtered 
through a 100 µm cell strainer to obtain a single cell suspension. 
In order to increase the density of goblet cells, the primary cell suspension was layered on 
a Percoll®/PBS (Sigma-Aldrich) density gradients which ranged from 18% to 57% (v/v; 
Figure 4.1A), and centrifuged for 10 minutes at 100 g with zero acceleration and deceler-
ation. Based on the results of gene expression study (Figure 4.1B) of the cells from each 
layer, 30% Percoll/PBS was chosen for further study. The top, bottom cell layers (Figure 
4.1A) and unseparated CECs were collected and seeded on tissue culture plates (TCP) pre-
treated with FNC coating mix (AthenaES, Baltimore, MD) respectively, at a density of 
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2×104 cells/cm2 and cultured at 37°C with 5% CO2. Bronchial Epithelial Cell Growth Me-
dium (BEGM™, with all supplements added; Lonza, Walkersville, MD) was changed 
every other day until cells reached confluence, in about 3-5 days. 
 
Figure 4.1. Separation of primary conjunctival epithelial cells by Percoll density gradient 
centrifugation. 
(A) Primary conjunctival epithelial cells were subject to a Percoll density gradient and the centrif-
ugation resulted in six cell populations; the percent (v/v) of Percoll in each layer was shown; (B) 




Rabbit lacrimal gland acinar cells (LGACs) Primary LGAC isolation was carried out as 
previous described. Inferior lacrimal glands from young rabbits were rinsed with 
DMEM/F12 (with 1% antibiotics-antimycotics) and finely minced into small pieces in a 
petri dish. The procedure was similar as previously described (69). The minced tissues 
were digested with an enzyme cocktail containing collagenase (Worthington Biochemical, 
Lakewood, NJ), hyaluronidase (Sigma-Aldrich) and DNase I (Roche) for 30 minutes at 
37°C with vigorous shaking. The cells were filtered through a 70 µm cell strainer and then 
subject to a Percoll® gradient to reduce fibroblast contamination. 
4.2.2. Submerged and airlifting culture of CECs 
Primary CECs were seeded on polyester Transwell® (Corning, Lowell, MA) membranes 
(0.4 µm pore size) at a density of 2×104 cells/cm2 and cultured at 37°C with 5% CO2. 
BEGM was added to both upper and lower compartments, and the inserts were kept at 37°C 
with 5% CO2 until the cells reached confluence in about 3-5 days. Afterwards, medium 
was switched to a 1:1 mixture of BEGM and DMEM/F12 in order to induce stratification. 
Induction medium was added to both upper and lower compartments of the Transwell in-
sert for submerged culture, while only the lower compartment had medium for airlifting 
culture, letting the cells on the membrane be exposed to air (Figure 4.2C). The induction 
was kept 1-2 weeks in the incubator at 37°C with 5% CO2. 
4.2.3. Spheroids formation and three-dimension (3D) culture of LGACs 
Primary LGACs were suspended at a density of 1×107 cells/mL in HepatoStim Medium 
(HSM) supplemented with 10 µg/mL epidermal growth factor (EGF) and 10% fetal bovine 
serum (FBS, Thermo). The suspension was added to a non-treated tissue culture flask 
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(Thermo) to prevent adhesion, and placed on an orbital shaker at 100 rpm for 24 hours in 
the incubator (37°C, 5% CO2). Cell spheroids were collected by centrifugation at 100 g for 
5 minutes. The spheroids were resuspended with Matrigel® matrix (growth factor reduced; 
Corning; 108 cells/mL of Matrigel). The mixture was added to TCP to form a thin layer of 
gel (100 µL/cm2) by incubating at 37°C for half an hour. HSM was changed every other 
day and images of spheroids encapsulated in Matrigel were taken using Axio Imager 2 
inverted fluorescent microscope (Carl Zeiss, Jena, Germany). The number and size of LG 
cell spheroids were analyzed using ImageJ software (National Institute of Health, NIH, 
Bethesda, MD). The spheroids were kept encapsulated in Matrigel for 1-2 weeks in the 
incubator (37°C, 5% CO2) until being harvested for analyses. 
4.2.4. Coculture of CECs and LG cell spheroids 
The coculture systems were demonstrated as in Figure 3a and 4a. LG cell spheroids were 
introduced into the system after CECs had been undergone airlifting culture for 5 days. 
Three different designs were utilized in this study. No contact model: a thin layer of Mat-
rigel with encapsulated LG cell spheroids was added to the bottom well of the Transwell 
system. Indirect contact model: the LG cell spheroids was put on the other side of the insert 
membrane; therefore, the two types of cells were separated by the porous membrane. Direct 
contact model: Matrigel containing LG cell spheroids were layered on top of CECs on the 
periphery of the insert. All coculture systems were established in 12-well Transwell system, 
and 50 µL Matrigel was used in all coculture models. The seeding density for each cell 
type was the same as it was in monoculture. HSM medium was added to the lower com-
partment of the Transwell system only, and the cocultures were maintained for one to two 
weeks before harvest. 
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4.2.5. Induction of dry eye-like inflammation with interleukin 1 beta (IL-1b) 
The direct contact coculture model was subject to IL-1b (Thermo) exposure, at a concen-
tration of 10 ng/mL. The direct contact coculture model was constructed as described above, 
with the addition of IL-1b in the medium. Dexamethasone (Sigma) was used as a treatment 
for IL-1b-induced inflammation. The cultures were maintained for one weeks, and the re-
sponse of the direct contact model to the exposure of IL-1b, dexamethasone and the two 
substances combined were analyzed. The results were also compared to monocultured sam-
ples under the same exposures. 
4.2.6. Reverse transcription and real-time quantitative polymerase chain reac-
tion (RT-qPCR)  
RT-qPCR analysis was used to quantify the gene expression of CECs, LG cell spheroids 
and the cocultured cells. Total RNA was extracted and purified using RNeasy Mini Kit 
(Qiagen, Valencia, CA) and the RNA concentration was measured by NanoDrop 2000 
(Thermo). cDNA synthesis was carried out with high capacity reverse transcription kit for 
RT-PCR (Thermo) according to the manufacturer’s protocol. Real-time PCR was per-
formed on the StepOnePlus™ Real-Time PCR System using SYBR® Green PCR Master 
Mix (Thermo). The relative expression level of all targets was calculated by the ΔΔCT 
method (50) and normalized against the control samples with β-actin as the endogenous 
reference. A full list of primer sequences could be found in Table 4.1. 
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forward CAA CCT GAA GAC CAC CAA GA 
reverse CAG AGT CTG GCA CTG CTT T 
MUC5AC 
forward CGC CTT CTT CAA CAC CTT CA 





forward CAA CGC GCT CAA CAA CAA 
reverse GTG AGT CGG TGG AAG AGA AA 
LTF 
forward GAT GCC ATG ACC CTG GAT AG 
reverse GTC TGT GGC TTC GCT TCT 
CDH1 
forward CAC CAT CGC CAT GAG TCT T 




forward GAA TAA TGA GAC CTG CCT GCT 
reverse TTC TTC GTC ACT CCT GAA CTT G 
IL-8 
forward TGG ACC TCA CTG TGC AAA T 
reverse GCT CAG CCC TCT TCA AGA AT 
TNFa 
forward GTA GTA GCA AAC CCG CAA GT 
reverse GGT TGT CCG TGA GCT TCA T 
MMP9 
forward AGT ACC GAG AGA AAG CCT ACT T 
reverse TGC AGG ATG TCA AAG CTC AC 
internal con-
trol B-actin 
forward GCT ATT TGG CGC TGG ACT T 
reverse GCG GCT CGT AGC TCT TCT C 
 
4.2.7. Histology preparation and stainings 
Both CECs cultured on TCP and Transwell membranes with cells (removed from the in-
serts with razor blades) were fixed with 4% paraformaldehyde (PFA; Electron Microscopy 
Sciences, Hatfield, PA) in PBS for 10 minutes at room temperature and washed three times 
with PBS. The Transwell samples were further dehydrated through ethanol gradients, 
cleared in xylenes, and embedded in paraffin. Sections of 5 µm thick were used for histo-
logical stainings. The samples were stained with Hematoxylin & eosin (H&E) and Periodic 
acid-Schiff (PAS) staining kits (Sigma-Aldrich) according to the manufacturer’s manuals 
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to visualize the morphology and detect the distribution of mucosubstances, respectively. 
Images of stained samples were taken on the Axio Imager 2 fluorescent microscope (Carl 
Zeiss). 
4.2.8. Immunohistochemistry 
TCP and Transwell samples were first fixed with 4% PFA at room temperature for 10-20 
minutes, followed by PBS rinse. F-actin was stained with alexa fluor® 647 phalloidin 
(Thermo) per manufacture’s instruction and then the nuclei were counterstained with 1 
µg/mL DAPI (4',6-diamidino-2-phenylindole dihydrochloride; Thermo) for 15 minutes. 
Staining with antibodies for the detection of specific antigens was performed as previously 
described (21). Anti-rabbit mucin 5AC, lysozyme and pan-cytokeratin monoclonal anti-
bodies were purchased from Abcam (Cambridge, MA); Anti-rabbit cytokeratin 4 mono-
clonal antibody was purchased from Sigma-Aldrich. Axio Imager 2 fluorescent microscope 
(Carl Zeiss) and confocal laser scanning microscope 510 (LSM 510; Carl Zeiss) were used 
for imaging.  
4.2.9. β-Hexosaminidase assay 
The secretion ability of LG cell spheroids was assessed by the measurement of β-N-Acetyl-
glucosaminidase (NAG), a lysosomal enzyme in the tear fluid secreted by lacrimal glands. 
The culture medium was replaced with DMEM/F12 and the cells were incubated at 37°C 
for 2 hours. Carbamylcholine chloride (carbachol, CCH; Sigma-Aldrich) was then added 
to the medium to a final concentration of 100 µM, and the samples were incubated for 
another 30 minutes. The media were collected and centrifuged at 200 g for 5 minutes. The 
resulting supernatants were analyzed for NAG catalytic activity with a NAG assay kit 
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(Sigma-Aldrich) per the protocol. The absorbance at 405 nm was measured using Synergy 
2 microplate reader (BioTek, Winooski, VT). The total protein content in the samples was 
measured by Pierce BCA protein assay kit (Thermo) per the instruction. 
4.2.10. Mucin layer visualization by confocal microscopy 
The mucins secreted by air-lifted samples were visualized and semi-quantified by loading 
a small amount (20 µL per 12-well insert) texas red conjugated dextran solution (10 kDa 
MW, 2 mg/mL in PBS; Thermo) in the upper chamber of Transwell inserts. The Transwell 
cultures were gently rinsed with warm PBS to remove secreted mucins before the addition 
of texas red-dextran. The inserts were incubated for 24 hours to allow mucin secretion and 
then examined using confocal microscopy with Z-stack scanning by LSM 510. The serial 
images were analyzed and stacked to generate 3D images for the measurement of mucin 
layer thin film with ZEN imaging software (Carl Zeiss) and ImageJ (NIH). 
4.2.11. Permeability tests with Dextran 
The function of CEC tight junctions was assessed by dextran permeability test. Texas red-
dextran (10 kDa; 10 mg/mL in PBS) was used in the study. Before the test, medium in the 
lower compartment in the Transwell was switched to serum free DMEM/F12; medium in 
the insert in submerged cultures was aspirated. Dextran solution was added in the insert 
and the Transwell cultures were incubated at 37°C, 5% CO2 for 30 minutes. The concen-
tration of texas red-dextran in both upper and lower compartments was calculated by meas-
uring the fluorescence on Synergy 2 microplate reader (excitation: 520 nm; emission: 590 
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nm). A serial concentration of texas red-dextran solution was made to construct the stand-
ard curve. Data was presented as percentage of dextran molecules that had diffused through 
the insert membrane. 
4.2.12. Statistical analysis 
Experiments were run by at least triplets, and results are presented as mean values ± stand-
ard deviation (SD). Data analysis was performed by GraphPad Prism, and the variance was 
analyzed by one-way ANOVA with post-hoc Tukey HSD for multiple comparison. Gen-
erally, a P value less than 0.05 was considered to be statistically significant. 
 
4.3. RESULTS 
4.3.1. Goblet cell enrichment and air-lifting culture of CECs 
Primary rabbit CECs were isolated from rabbit conjunctival tissues. Goblet cells were en-
riched using a Percoll gradient where six different layers were tested (Figure 4.1A). Cells 
in layers 1 and 2 expressed significantly lower levels of cytokeratin 4 (CK4) and mucin 
5AC (MUC5AC) compared to the cell population before Percoll separation (Figure 4.1B). 
Therefore, 30% Percoll/PBS solution was selected for goblet cell enrichment for all subse-
quent studies, and the three cell populations were named as top, bottom (enriched), and 
control (unseparated) (Figure 4.1A). In general, the enriched CECs expressed significantly 
more CK4 and MUC5AC mRNAs than the control, while the top layer had much less ex-
pression of CK4 (< 0.3-fold), and expression of MUC5AC was undetectable (Figure 4.2A). 
63	
Enriched CECs also expressed more epithelial markers in culture and secreted more mu-
cosubstance when compared to unseparated control, as confirmed by CK4, PAS, and 
MUC5AC stainings, respectively (Figure 4.2B). 
Airlifting culture was compared to submerged culture to optimize the mucin secretion by 
CECs in vitro (Figure 4.2C). After one week of airlifting, CECs stratified into 5-6 layers 
of epithelial cells, while submerged culture had less than two layers of cells (Figure 4.2D). 
Immunohistochemistry for CK4 and MUC5AC (Figure 4.2F) confirmed improved epithe-
lial and goblet cell differentiation as well. Airlifting also significantly benefited the mucin 
secretion of CECs. Three-dimensional confocal z-scanning of the mucin layer, stained by 
Texas Red-dextran, confirmed that airlifting resulted in a thicker and more continuous ex-
tracellular mucin secretion (Figure 4.2G). The side view of the confocal z-scanning indi-
cated an overall thicker mucin layer (50.0 ± 5.0 µm for airlifting culture and 15.0 ± 1.7 µm 
for submerged culture). Though CK4 expression was the same in both cultures, airlifting 






Figure 4.2. Goblet cell enrichment and airlifting culture of conjunctival epithelial cells (CECs). 
(A) Gene expression (RT-qPCR; fold change is expressed as 2-DDCT) of CECs before (control) and after goblet cell enrichment. CECs were separated 
into two populations after Percoll gradient separation – top and bottom (enriched). (B) Stainings (PAS, CK4 and MUC5AC immunostainings) 
comparing the phenotypes of CECs with or without goblet cell enrichment. Scale bar 200 µm. (C) The schematics for airlifting (AL) and submerged 
(SM) cultures of CECs based on Transwell insert. H&E staining (D) and RT-qPCR (E) comparing CECs under AL and SM culture. Scale bar 100 
µm. (F) IHC (top: CK4; bottom: MUC5AC) showing the difference in cell phenotypes between AL and SM cultures. Scale bar 50 µm (G) Mucin 
secretion (stained by Texas red labeled dextran) visualized by confocal microscope (z scan). Both side view and 3D views are shown. Scale bar 100 




4.3.2. The formation and development of 3D LG cell spheroids in Matrigel 
Primary rabbit LGACs spontaneously formed spheroids after 24 hours on the orbital shaker, 
and the average diameter of the spheroids was 124 ± 19 µm (Figure 4.3). The spheroids 
underwent structural development in Matrigel to produce glandular tissue. After encapsu-
lation, the LG cell aggregates formed spheroids at day two (Figure 4.4A), and continued to 
develop into multi-branched organoids by day five (Figure 4.4B). Phalloidin staining re-
vealed formation of hollow cavities inside the spheroids (Figure 4.4C). By day 5, each 
spheroid further developed multiple acinus-like compartments (Figure 4.4D). The LG cell 
spheroids stained positive for both epithelial maker pan-cytokeratin (PCK, Figure 4.4E) 
and lysozyme (LYZ, Figure 4.4F). 
Next, the function of LG cells in 2D monolayer or 3D spheroids in Matrigel matrix was 
compared (Figure 4.4G). Three-dimensional culture influenced tear film secretion on the 
transcriptional level. The genes aquaporin 5 (AQP5) and lactoferrin (LTF) increased 4- and 
2.5-fold, respectively, in the 3D culture (Figure 4.4H). Media supernatants and cell lysates 
were collected to measure the concentration of active lysozyme in the tear film secreted by 
the lacrimal glands. The cell lysate of LG cells cultured in 2D monolayer had a higher level 
of active lysozyme, but the lysozyme concentration in the supernatant of 3D spheroid cul-




Figure 4.3. Size distribution of lacrimal gland spheroids. 
(A) A typical image of lacrimal gland spheroids. Five similar images were used for size analysis 
by Image J) Scale bar 400 µm. (B) Size distribution histogram of lacrimal gland spheroids. The 






Figure 4.4. 3D lacrimal gland (LG) cell spheroids formation and culture. 
(A) Schematics of LG cultured as either 2D monolayer or 3D spheroids embedded in Matrigel. (B) 
Gene expression (RT-qPCR; fold change is expressed as 2-DDCT) and (C) β-hexosaminidase assay 
comparing LG cells culture under 2D and 3D conditions. Both supernatant and cell lysate were 
collected for hexosaminidase assay and the value (units) was normalized to total protein content 
(mg). (D-G) Phase contrast and F-actin staining (Phalloidin) images of LG spheroids in Matrigel 
at different stages. (D,F) day 1; (E,G) day 5. (H,I) IHC showing the expression of LG specific 
markers. (H) Pan-cytokeratin; (I) lysozyme. Scale bar: 100 µm (D,E); 50 µm (F-I). *p < 0.05; **p 
< 0.001.  
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4.3.3. Coculture of airlifted CECs and LG cell spheroids 
Airlifted CECs and LG cell spheroids were cultured together to study the effect of coculture 
on tear secretion and gene expression. Stratified CECs were on the upper compartment and 
encapsulated LG cell spheroids were on the lower compartment. The two monoculture 
groups were composed of either the LG cell spheroids, or air-lifted CECs (Figure 4.5A). 
By day 10, air-lifted CECs under both coculture and monoculture conditions secreted a 
continuous layer of extracellular mucins. The average thickness of mucin film secreted by 
cocultured CECs was 45.8 ± 5.3 µm, as compared to 30.0 ± 5.0 secreted by monocultured 
CECs (Figure 4.5D). The media supernatants and LG cell lysates were collected for the 
measurement of lysozyme concentration. At day four, cocultured LG cell spheroids se-
creted more than 10 times the amount of active lysozyme into the media supernatant com-
pared to monocultured LG cell spheroids; however, this difference decreased at day 10 
(Figure 4.5E). Regarding the cell lysates, coculture was beneficial for lysozyme synthesis 
at day 4; however, monocultured LG cells contained more NAG than cocultured cells at 
day 10. Regarding gene expression, the cocultured group reported elevated level of CDH1 
and MUC5AC at day four, and LTF and CK4 at day 10 (Figure 4.5B,C). Gene expression 





Figure 4.5. Coculture of conjunctival epithelium and lacrimal glands. 
(A) Schematics showing the setup of coculture in the Tranwell system. Airlifted CECs cultured on 
the insert was combined with LG/Matrigel in the lower compartment to achieve coculture. In mon-
ocultures, only one cell population was present. (B,C) The difference in gene expression between 
monocultures and cocultures. (B) Conjunctival epithelium specific markers; (C) lacrimal gland 
specific markers. Samples at day 4 and 10 were collected and analyzed. Control in (C) was LG 
cells culture in 2D monolayer. (D) Confocal (z scan) microscopic image of the secreted mucin layer 
from airlifted CECs cultured in monocultures and cocultures. Scale bar 100 µm. (E) β-hexosamini-
dase assay of LG cell lysates and supernatants. Samples at day 4 and 10 were collected and ana-
lyzed. *p < 0.05; **p < 0.001. 
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4.3.4. The influence of cell contact on the secretory function in coculture 
Different coculture architectures were developed to investigate the influence of cell contact 
on the function of the in vitro model system. The three designs tested were based on the 
degree of contact between the two cell types: (I) Bottom: no cell contact, (II) Membrane: 
indirect cell contact (separated by a porous membrane), and (III) Top: direct cell contact 
(Figure 4.6A). Permeability test with 10 kD Texas Red-dextran (Figure 4.6B,C) was con-
ducted to assess the tight junctions of CECs in different coculture models. Less than 17% 
of dextran diffused through during this experiment in all three models. Moreover, when 
there was indirect or direct cell contact between the two cell populations, the diffusion 
percentage reduced to about 10%, significantly lower compared to the no cell contact 
model. 
The level of cell contact also impacted the level of gene expression and protein secretion 
in the coculture models. The amount of LTF mRNA in the direct cell contact model was 
twice as much as those in the other two models (Figure 4.6D). This same trend was ob-
served in the measurement of secreted mucin layer, with average mucin thickness values 
for models (I)-(III) of 31.5 ± 1.7 µm, 40.3 ± 2.5 µm, and 82.1 ± 4.0 µm, respectively (Figure 
4.6E). Specifically, direct cell contact between CECs and LG cell spheroids gave rise to 




Figure 4.6. Influence of coculture setups on in vitro ocular surface and tear film. 
(A) The three different designs of coculture system, which were named after the relative interactions between CECs and LG spheroids. (B,C) 
Diffusion study (with fluorescent 10 kD dextran). Data in (C) was presented as percent of dextran diffused through. (D) LTF gene expression across 
the three coculture designs. (E) Secreted mucin layer from airlifted CECs in coculture, visualized by confocal microscopes (z scan). Scale bar 100 
µm. (F) MUC5AC IHC staining (red fluorescence; nuclei were counterstained with DAPI) of the airlifted CECs. Scale bar 50 µm. *p < 0.05; **p < 
0.001.
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4.3.5. Direct cell contact coculture system as a complex 3D dry eye model in 
vitro 
Using the coculture system that provided the best mimic for the ocular surface tear film, 
response to inflammation-inducing molecules was tested. Specifically, the direct cell con-
tact model system was exposed to the proinflammatory cytokine IL-1b and the commonly 
used therapeutic dexamethasone. IL-1b exposure upregulated the mRNA level of various 
cytokines and chemokines, including IL-6, IL-8, tumor necrosis factor alpha (TNFa), and	
matrix metalloproteinase-9 (MMP9), at both six- and 24-hour time points (Figure 4.7A and 
Figure 4.8A). Dexamethasone was effective in downregulating these genes at the 24-hour 
time point (Figure 4.8A). Cytokine exposure also changed the expression of ocular surface 
specific genes (Figure 4.7B,C and Figure 4.8B,C). The level of CK4 and AQP5 was re-
duced, while LYZ expression was increased upon the addition of IL-1b. When CECs or 
LG cell spheroids were cultured alone, IL-1b also induced significant changes in gene ex-
pression. However, the addition of dexamethasone was ineffective in restoring the mRNA 
level of either proinflammatory or tissue-specific genes (Figure 4.9), highlighting the im-
portance of the coculture system in providing a physiologically-relevant screening re-
sponse. 
IL-1b exposure resulted in thinning of the conjunctival epithelial in the ocular surface 
model. Treatment with dexamethasone restored the thickness of epithelium after IL-1b ex-
posure (Figure 4.8D). A similar trend was observed with MUC5AC staining (Figure 4.8E), 
in which goblet cells (MUC5AC+) were almost absent with IL-1b culture. IL-1b also sig-
nificantly decreased the thickness of the tear film secreted by the model system (Figure 
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4.8F), while the combination of IL-1b and dexamethasone increased lysozyme secretion 





Figure 4.7. Influence of IL-1b addition in the coculture system on gene expression at early 
time point (six hours). 
(A-C) Gene expression of the coculture system after the addition of IL-1b. (A) Inflammatory genes; 





Figure 4.8. Responses of direct contact coculture model after cytokine IL-1b stimulation. 
(A-C) Gene expression of the coculture system after the addition of IL-1b. (A) Inflammatory genes; (B) conjunctival epithelial specific genes; (C) 
lacrimal gland specific genes. (D) The change of epithelial thickness and morphology (H&E staining) after IL-1b exposure. Scale bar 100 µm.  (E) 
MUC5AC staining of the airlifted CECs under various conditions (top view). Scale bar 200 µm. (F) Mucin layer secreted by airlifted CECs imaged 
by confocal z-scanning. The thickness values were measured using ImageJ. Scale bar 100 µm.  (H) β-hexosaminidase assay (supernatant of LG 





Figure 4.9. Responses of cells under monoculture after cytokine IL-1b stimulation. 
Gene expression of monocultured LG spheroids and CECs when exposed to IL-1b. (A) Proinflam-
matory factors; (B) Lacrimal gland specific genes; (C) Conjunctival epithelial specific genes. Dex: 




Conjunctival epithelium, goblet cells, and lacrimal glands are parts of the ocular surface 
and tear film system. The mucin-aqueous layer in the tear film is of essential importance 
in protecting the ocular surface epithelium, and is frequently damaged in dry eye disease. 
Therefore, we constructed a model system for rabbit ocular surface in which the synergistic 
interactions between conjunctival epithelium and lacrimal glands can be realized and pre-
cisely examined. 
Coculture is a common technology utilized in tissue engineering to study the natural and/or 
synthetic interaction between cell populations, and to improve in vitro culture time (70). In 
the ocular system, coculture of RPE and photoreceptors was able to provide a better mimic 
of retinal differentiation and morphology (64). Dry eye is an internationally prevalent dis-
ease with few efficacious therapies. Besides animal models, robust in vitro models of the 
ocular surface and tear film provide a tool to study pathogenesis and to improve drug 
screening. Thus, we cocultured conjunctival epithelial and lacrimal gland cells, two im-
portant components for tear secretion, in the ocular surface model system. The coculture 
system was compared to monocultures with respect to the expression of tear secretory 
markers. Goblet cells in coculture contributed to a thicker mucin layer, and LG cell sphe-
roids had elevated secretion as well. Coculture also helped maintain the morphology and 
phenotype of the two cell populations (Figure 4.5). 
To create functional tissue mimics, we need to consider the effect of cell contact. Different 
organ/tissue systems require special consideration while designing coculture models. For 
example, Wallace CS et al. developed tissue engineered blood vessel model by coculturing 
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endothelial (ECs) and smooth muscle cells (SMCs). In this model quiescent SMCs reduced 
the inflammatory response of ECs mediated by TNFa (71). To find the most effective co-
culture model and analyze the secreted tear fluid, three different coculture models were 
compared (Figure 4.6). Results of the permeability test confirmed that the tight junction of 
conjunctival epithelium is not compromised by the introduction of cell contact in models 
(II) and (III). The thickness of tear fluid increased significantly with more cell contact 
(Figure 4.6E), especially in the direct cell contact model (III). Because the stratified CECs 
remained as a barrier between the LG cell spheroids and the medium reservoir below, the 
tear fluid secreted by LG cell spheroids accumulated on the top chamber instead of diffus-
ing into the reservoir. This resulted a mixture of both mucin and aqueous layers. This de-
sign allows the extraction of the secreted tear fluid for further proteomics and rheological 
analyses. 
Although conjunctival epithelium and lacrimal glands do not have direct contact anatomi-
cally, the unique organization of the two cell populations in the direct contact model leads 
to greatly improved tear secretory function compared to other models. It provides an inno-
vative design for the collection and analysis of secreted tear fluid. Moreover, the unique 
architecture supported long term culture in vitro. We tested this specific model system as 
a mimic for aqueous dry eye disease, induced by IL-1b, an early molecular mediator in the 
progression of inflammatory diseases (72). After IL-1b exposure, at early time points, we 
observed changes in the mRNA level of various proinflammatory factors as well as tear-
secretory markers. At later time points, the number of goblet cells was reduced significantly, 
and tear secretion from both cell populations decreased when IL-1b was present. Epithelial 
damage and thinning were also observed, possibly due to the release of MMPs (Figure 4.8). 
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Dexamethasone is an anti-inflammatory corticosteroid, known to be beneficial in treating 
dry eye disease (73), and it was able to counteract the effect of IL-1b on our model system. 
The outcomes we observed in the direct cell contact model system mimic moderate dry eye 
symptoms in animal models (74). Monocultured CECs and LG cell spheroids both showed 
altered gene expression in response to IL-1b. However, treatment with dexamethasone 
could not alleviate these symptoms (Figure 4.9). Therefore, the complex 3D coculture sys-
tem is a more reliable dry eye model in vitro compared to monocultured models because it 
provides a physiologically-relevant response to treatment, and is necessary for the accurate 
evaluation of therapeutic effects. For further analyses and improvement of the model, hu-
midity and air flow rate could be controlled for more accurate mimicking of dry eye disease, 
and rabbit primary cells could be substituted with human cells as well. 
The mucin layer of the tear film is critical in maintaining homeostasis of the ocular surface. 
Low goblet cell density and a disrupted mucin layer could accelerate the vicious cycle in 
the development of dry eye (75). Previously established conjunctival epithelial models 
have lower percentages of goblet cells than their corresponding native tissue (54). To en-
sure adequate goblet cell number and mucin secretion, CECs were subject to Percoll den-
sity separation and airlifting culture. After Percoll separation, the gene expression results 
indicated that the bottom cell population was enriched with MUC5AC positive goblet cells, 
as well as CK4 positive epithelial cells. With the Percoll gradient enrichment, primary 
CECs were able to give rise to more goblet and epithelial cells in culture, confirmed by 
immunocytochemistry (Figure 4.2A,B). Airlifting culture is essential for goblet cell matu-
ration and mucin secretion, and the development of a normal mucin layer in the tear film 
(76). After one week of airlifting culture, cells stratified into four to five layers of CK4 
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positive epithelial cells and MUC5AC producing goblet cells (Figure 4.2C-F). Airlifted 
CECs also secreted a thicker and more homogenous mucin-aqueous thin film, labeled by 
fluorescent dextran (Figure 4.2G). 
Lacrimal glands are the main secretory source of the aqueous tear components. Aqueous 
deficient dry eye usually involves decreased secretion and inflammation in the lacrimal 
glands (58). A 3D environment is required for the successful mimicking of this condition. 
To investigate the mechanism of lacrimal gland secretion and dry eye disease, various 
methods have been attempted to recapitulate the 3D environment in vitro, including rotary 
cell culture system (77) and gel encapsulation (78). We employed a simple yet effective 
method to form homogenous LG cell spheroids by self-assembly, which were later har-
vested and encapsulated in Matrigel. The spheroids underwent organoids development, 
formed hollow cavities first, and then were interconnected together with ductal structure 
into multi-branched lobules with lumens. These lacrimal organoids were functionally ac-




In summary, we engineered a synthetic coculture model system, composed of conjunctiva 
epithelium and LG cell spheroids, as a recapitulation for the ocular surface and aqueous 
tear system. We demonstrated the efficacy of this model system as a mimic for both the 
healthy ocular surface and aqueous dry eye disease induced by inflammation. Our model 
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system provides a novel platform for the pathophysiological study of the ocular surface, as 
well as for the discovery of new therapeutics for dry eye disease. 
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Chapter 5. Anti-Inflammatory and Anti-Fibrotic Tissue Matrix Parti-




Extracellular matrices (ECMs) are the molecular networks synthesized and secreted by 
nearby cells. They offer structural support for tissues and organs, serve as reservoirs for 
growth factors and provide binding sites for cell migration. ECM plays an important role 
in the physiological development of both regular tissue and many diseases, including can-
cer (79). It offers mechanical support and provides biologically functional molecules dur-
ing tissue remodeling and wound healing (80). Therefore, ECMs have been widely em-
ployed as natural biomaterials in regenerative medicine, and the most widely used and 
studied ECMs are derived from small intestine submucosa and urinary bladder (81, 82). To 
increase the biocompatibility, tissue ECMs can be decellularized mechanically and/or 
chemically to remove cellular contents (83). Decellularized ECM still preserves the func-
tional and structural features of the original tissue, and it also exhibits immunoregulatory 
effect by inhibiting rejection and driving the macrophage response towards the M2 (anti-
inflammatory) lineage during xenotransplantation (84). ECM materials lost load-bearing 
ability after pulverization and become micron-sized powders, however, they can provide 
more advantages by serving as reservoirs for signaling molecules. Furthermore, the degra-
dation rate of particularized ECM materials could be fine-tuned to match the remodeling 
rate of target host tissue (85). 
83	
On the ocular surface, cornea, conjunctiva, lacrimal glands and meibomian glands work 
together as one integrated unit to protect the homeostasis and function of the anterior part 
of the visual system (1). Ocular surface environment is largely affected by intrinsic and 
extrinsic immunological factors in case of injuries and diseases (86), which involves inter-
action of cells, ECM and the tear film, and is mediated by a cascade of cytokines and 
chemokines (87, 88). Although cornea is an immune-privileged organ (89), and wound 
healing is relatively simple in the ocular surface comparing to other organs, inappropriate 
healing of the cornea leads to fibrosis that severely impacts vision and quality of life (88). 
ECM remodeling during corneal wound healing is regulated by the crosstalk between dif-
ferent parts of the cornea, the binding of ECM and cell surface molecules, and many mo-
lecular mediators, including the key players during this process, tumor growth factor-b 
(TGF-b) (90). Tear film is secreted by various parts on the ocular surface, and its compo-
nents and secretion are also altered when cornea is injured. Higher concentration of growth 
factors and proinflammatory cytokines, epithelial damage and reduced tear production are 
signs of dry eye disease observed after corneal refractive surgeries (88, 91). Corneal inju-
ries in the context of pre-existing dry eye conditions are more prone to exacerbated immune 
response and corneal perforation (92). Therefore, while developing new therapies for cor-
neal wound healing, we need to investigate their regulatory effect on the whole ocular sur-
face system, instead of focusing only on the cornea. 
Several approaches have been applied to reduce scar formation during corneal wound heal-
ing, such as transplantation with stem cells from various sources (93-95). There cells are 
shown to have anti-inflammatory effect as they suppressed the infiltration of immune cells 
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after corneal injuries. Decellularized ECMs from various tissues and organs have been in-
vestigated as biomaterial scaffolds for cell culture in vitro or implantations in vivo (83). In 
general, they promote regeneration and inhibit inflammatory response and fibrosis in many 
clinical applications, including the repair of skeletal muscle, cartilage and urinary tract (80). 
Since ECM derived scaffolds have yet to be studied thoroughly in the ocular surface system, 
we utilized them as new therapeutics to regulate the homeostasis of the ocular surface and 
to achieve optimal corneal wound healing. Therefore, we studied ECM biomaterials de-
rived from several tissue sources, including porcine lymph nodes (LN), cornea (CO) and 
cartilage (CA). The tissues were decellularized and pulverized into micro-particles. We 
first investigated their anti-inflammatory effect on ocular surface cells in vitro. ECM par-
ticles, especially LN-ECM, ameliorated the inflammation of ocular surface cells induced 
by cytokines. LN-ECM was applied on a rabbit lamellar keratectomy model to promote 
corneal stromal reconstruction and decline scar formation. Overall, LN-ECM regulated the 
wound healing process by decreasing the expression of inflammatory mediators, and suc-
cessfully reduced immune cell infiltration in the wounded area, and prevented corneal fi-
brosis. 
 
5.2. MATERIALS AND METHODS 
5.2.1. Preparation of particulate ECM 
ECM particles were prepared as previously described (96). Briefly, fresh porcine lymph 
nodes, corneas and cartilage were purchased from an US certified butcher (Wagner’s Meats, 
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Mt. Airy, MD) and frozen at -20 °C. The thawed tissue was grounded manually and decel-
lularized in 3% peracetic acid (Sigma-Aldrich, St. Louis, MO) at 37 °C for 4 hours and 
then in 1% Triton-X100 (Sigma-Aldrich) with 2 mM ethylenediaminetetraacetic acid 
(EDTA; Sigma-Aldrich) at room temperature for 48 hours under continuous agitation. Af-
ter cellular components were removed, 0.03% DNase I (Roche Diagnostics Corp, Indian-
apolis, IN) treatment was performed at 37°C for 24 hours. The decellularized ECM was 
lyophilized, pulverized using cryomill (SPEX 6770, SPEX SamplePrep, Metuchen, NJ) 
and stored at -20 °C until use. 
5.2.2. Morphology and size distribution of particulate ECM 
The morphology of ECM particles was characterized by field-emission scanning electron 
microscopy (SEM; Carl Zeiss, Jena, Germany). Lyophilized ECM particles were taped on 
the SEM sample stage with carbon tape, and sputter coated at 20 mA, 5 cm working dis-
tance with 0.1 mbar, for 120 seconds, to achieve a 10-nm coating. Images were taken under 
1.0 kV, 2 mm working distance. 
Average particle size and particle size distribution of each type of particulate ECM were 
determined by a dynamic light scattering method using Zetasizer Nano ZS90 (Malvern 
Instruments, Malvern, UK) at 25 °C. Samples were diluted with distilled water before 
measurement. 
5.2.3. Ocular surface cell isolation and culture 
Cells on the ocular surface were isolated from Young New Zealand white rabbit tissue 
(eyes and lacrimal glands), purchased from Pel-Freez Biologicals (Rogers, AR). 
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Rabbit lacrimal gland acinar cells (LGACs) 
Inferior lacrimal glands were removed aseptically and finely minced and cell isolation was 
carried out as previously described (97). Briefly, the tissue was enzymatically digested by 
collagenase (350 U/ml; Worthington Biochemical Corp, Lakewood, NJ), DNase I (40 U/ml; 
Roche) and hyaluronidase (300 U/ml; Sigma-Aldrich) for 45 minutes at 37°C, and the di-
gests were filtered through a 100 µm cell strainer and then centrifuged at 200 g for 5 
minutes. Cells were resuspended in HepatoStim culture medium supplemented with epi-
dermal growth factor (EGF; 5 ng/mL; Corning, Tewksbury, MA). The LGACs were seeded 
on Matrigel® (growth factor reduced, Corning) coated wells at a density of 5×105 cells/cm2 
at 37°C with 5% CO2. 
Rabbit conjunctival epithelial cells (CECs) 
Conjunctival tissue was removed from rabbit eyes, with excessive Tenon's tissue trimmed 
off. The tissue was digested with Dispase®II (1.2 U/ml; Roche) at 4 °C overnight. The 
loosened epithelial aggregates were dispersed from the surface with a cell scraper, and then 
collected by centrifugation at 200 g for 5 minutes. The CECs were separated into single 
cells by a secondary digestion with Accutase® (Sigma-Aldrich) for 10 minutes at 37°C 
and filtered through a 100 µm cell strainer. The final cell pellet was resuspended in sup-
plemented bronchial epithelial cell growth medium (BEGM; Lonza Inc, Walkersville, MD). 
Isolated cells were seeded at a density of 5×104 cells/cm2 on tissue culture plates at 37 °C 
with 5% CO2.  
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The air-lifting culture of CECs was performed according to previous study (43). CECs 
began to stratify into multiple layers in air-lifting condition and the air-lifting culture was 
maintained for 7 days at 37 °C with 5% CO2 for downstream experiments. 
Rabbit corneal keratocytes 
Keratocytes were isolated using a sequential collagenase (3.3 mg/mL; Worthington) diges-
tion (31). Briefly, corneas were diced into quarters and digested in 3.3 mg/mL collagenase 
solution on an orbital shaker at 37 °C. The digests were collected and filtered through 70 
µm cell strainer after 30, 60 and 180 minutes of digestion, and each time fresh collagenase 
solution was added. Keratocytes were pelleted by centrifugation at 200 g for 10 min, and 
seeded at a density of 2×104 cells/cm2 on tissue culture plates with EpiLifeÒ medium 
(Thermo Fisher Scientific, Waltham, MA) at 37 °C with 5% CO2. 
5.2.4. Interleukin-1 beta (IL-1β) stimulation and particulate ECM treatment 
in vitro 
Inflammation of ocular surface cells was induced with IL-1β (20 ng/ml, Thermo Fisher 
Scientific) after the cells reached confluence. To compare their anti-inflammatory and se-
cretion stimulatory effects, various types of ECM particles (lymph nodes, cornea and car-
tilage) were added to the media at a concentration of 1 mg/mL. Cells were maintained for 
48 hours and then harvested for gene and protein expression analyses. Cells cultured under 
standard conditions without IL-1β stimulation or ECM particles were used as the controls.   
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5.2.5. F-actin staining of keratocytes 
Alexa Fluor 488 Phalloidin (Thermo Fisher Scientific) was used to visualized the morphol-
ogy of keratocytes. The cells were rinsed with phosphate buffered saline (PBS; Thermo 
Fisher Scientific) and fixed with 4% paraformaldehyde (PFA; Sigma-Aldrich) solution for 
10 min, followed by permeabilization with 0.1% Triton X-100 for 20 min at room temper-
ature. After thorough rinse with PBS, the keratocytes were stained with Phalloidin for 20 
min in the dark, followed by counterstaining with DAPI (4',6-diamidino-2-phenylindole 
dihydrochloride; Thermo) for the nuclei. The cells were imaged using a fluorescent micro-
scope (Axio Imager 2, Carl Zeiss, Jena, Germany). 
5.2.6. β-hexosaminidase secretion assay 
β-hexosaminidase, or N-Acetylglucosaminidase (NAG) is a lysosomal enzyme in the tear 
fluid secreted by lacrimal glands after carbachol stimulation, and 4-Nitrophenyl N-acetyl-
β-D-glucosaminide (NP-GlcNAc) was used as the substrate for NAG. Secretion assay was 
carried out with four replicates in each group. The culture medium was replaced with 
DMEM/F12 (Thermo Fisher Scientific) and incubated at 37°C for 2 hours. After removing 
a baseline sample, carbachol (Sigma-Aldrich) was added to the medium to a final concen-
tration of 100 µM, and incubated at 37°C for 30 minutes. The culture medium was collected 
and centrifuged at 700 rpm for 5 minutes. The resulting supernatants were analyzed for 
NAG catalytic activity with a NAG assay Kit (Sigma-Aldrich), per the protocol. The ab-
sorbance at 405 nm was measured using a microplate reader (BioTek, Winooski, VT).  
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5.2.7. Confocal microscopy measurement of secreted mucin in vitro 
Similarly, after seven days of air-lifting culture, CECs cultured on TranswellÒ (Corning) 
were exposed to IL-1β (20 ng/ml) and each ECM particles for 48 hours. Texas Red-dextran 
(10 kDa, 2 mM in PBS; Thermo Fisher Scientific) solution was loaded onto upper chamber 
of TranswellÒ insert. Z-stack scanning was performed on the samples by a laser scanning 
confocal microscope (LSM 510, Carl Zeiss). The serial images were analyzed and stacked 
to generate 3-dimensional images for the measurement of mucin thin film thickness using 
ZEN imaging software (Carl Zeiss). 
5.2.8. Animal surgeries and the application of ECM particles on corneal 
wound 
New Zealand White rabbits, weighing between 2-3 kg, were used in the corneal wound 
healing study. The animals involved were housed and treated in accordance with the guide-
lines in the Association for Research in Vision and Ophthalmology (ARVO) Statement for 
the Use of Animals in Ophthalmic and Visual Research and also with the approval of the 
Animal Care and Use Committee at Johns Hopkins University at all time. They were anes-
thetized by intramuscular injection of ketamine (15 mg/kg) and xylazine (5 mg/kg). Cor-
neal stromal injuries were introduced with superficial lamellar keratectomy (SLK) using 
an automated microkeratome (Bausch & Lomb, Rochester, NY). The dimension of the 
wound was 6 mm in diameter and 100 µm in depth on average. The corneal flaps were 
surgically removed, leaving the corneal stroma exposed (untreated; Figure 5.4A). 
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Fibrin glue (FG; Baxter, Deerfield, IL) sealant was used as a positive control treatment for 
wound healing, as well as the delivery agent of ECM particles. After SLK, 10 µL fibrino-
gen solution was first pipetted on top of the corneal wound, followed by the addition of 10 
µL thrombin solution. The mixture was allowed to gel at room temperature for 5 min to 
form a layer covering the wounded area. LN-ECM powder was mixed with fibrinogen so-
lution before adding to the corneal wound, and the final ECM concentration in FG gel was 
30 mg/mL. A topical antibiotic ointment (0.5% erythromycin; Wilson, Mustang, OK) was 
applied after the procedures and every day afterwards, while no systemic and local immu-
nosuppressive agents were used. 
5.2.9. Clinical observations of re-epithelialization and corneal haze analysis 
The epithelialization of cornea was evaluated by fluorescein staining under blue light every 
day in the first week post-surgery until completed healing. The area of cornea stained with 
fluorescein was measure using ImageJ software (National Institute of Health, NIH, Be-
thesda, MD), and normalized to the whole cornea and this value was used for comparison 
between groups (Figure 5.5A,C). 
The eyes are also examined and photographed throughout the study by a slit lamp to assess 
corneal scar and haze formation. The amount of corneal haze was quantified with Pho-
toshop software (Adobe Systems Inc., San Jose, CA) similarly as previously described (98). 
Front image of the corneas was converted to gray scale for better contrast. The “set black 
point” option in Photoshop was used for background correction, in which a point on the 
cornea above the pupil with no haze was set to be black. Hence the scarring area of each 
image was normalized to its respective unscarred regions, making the comparison more 
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accurate. The area above the pupil was selected using the “elliptical marquee tool” and the 
measurement was recorded (Figure 5.5B). The value of “integrated density” was used for 
analysis, as it is related to both brightness and area of the haze. 
Scar tissue within corneal stroma was imaged at various time points by an in vivo confocal 
microscope (Nidek Confoscan 3, Fremont, CA, USA) similarly to a pervious study (99). 
Briefly, immediately after anesthesia, rabbits were placed on a customized platform and 
the heads were immobilized with one of the eyes facing towards the objective lens. Corneal 
stromal tissues of different layers (anterior, mid and posterior) were imaged using the Con-
foscan 3 software. Lubricant gel (Genteal; Novartis, East Hanover, NJ) was used through-
out the imaging as an immersion fluid. 
5.2.10. Quantitative real-time polymerase chain reaction (RT-qPCR) 
Cornea samples in vivo were collected at one- and four-week post-surgery. After euthana-
sia, corneas were dissected off the eye and frozen at -80 °C in TRIzolÒ reagent (Sigma-
Aldrich), and followed by cryogenically homogenization with mortar and pestle while im-
mersed in liquid nitrogen. The homogenate was collected and used for total RNA isolation 
as follows. 
Total RNA from cells growing in vitro and cornea samples in vivo was isolated using the 
RNeasy Mini Kit (Qiagen, Germantown, MD), according to manufacturer’s protocol. The 
RNA concentration was measured using a NanoDrop Spectrophotometer (NanoDrop Tech-
nologies, Wilmington, DE). cDNA was synthesized from 1 µg of total RNA with the high-
capacity cDNA reverse transcript kit (Thermo Fisher Scientific) on a MyCycler (Bio-Rad, 
Hercules, CA) thermal cycler. qPCR was conducted on the StepOnePlus System (Thermo 
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Fisher Scientific) using SYBR Green PCR Master Mix (Thermo Fisher Scientific) to quan-
tify the expression level of target genes. Primer sequences are listed in Table 5.1. Relative 
quantification of the signals was carried out by the ΔΔCT method with the expression level 
normalized to that of control samples. β-actin was used as internal reference.  
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forward GAG TCA CAG TGC GTG ATG TT 
reverse GGC CAG GGC TAT GAA ATA GAT G 
MUC5AC 
forward CGC CTT CTT CAA CAC CTT CA 




forward CAA CGC GCT CAA CAA CAA 
reverse GTG AGT CGG TGG AAG AGA AA 
LTF 
forward GAT GCC ATG ACC CTG GAT AG 
reverse GTC TGT GGC TTC GCT TCT 
inflammatory 
IL-6 
forward GAA TAA TGA GAC CTG CCT GCT 
reverse TTC TTC GTC ACT CCT GAA CTT G 
IL-8 
forward TGG ACC TCA CTG TGC AAA T 
reverse GCT CAG CCC TCT TCA AGA AT 
TNF 
forward GTA GTA GCA AAC CCG CAA GT 
reverse GGT TGT CCG TGA GCT TCA T 
MMP9 
forward AGT ACC GAG AGA AAG CCT ACT T 
reverse TGC AGG ATG TCA AAG CTC AC 
iNOS 
forward CCA TCC CTG CAT CCT CAT T 
reverse CCG GAG CCC TTT GTA CTC 
Arg1 
forward ACT CCA CTG ACA ACC ACA AG 
reverse CCT GGT ACA TCA GGG ATC TTT C 
fibrotic 
TGF 
forward CCT GTA CAA CCA GCA CAA CC 
reverse CGT AGT ACA CGA TGG GCA GT 
CTGF 
forward AGG AGT GGG TGT GTG ATG AG 
reverse CCA AAT GTG TCT TCC AGT CG 
COL1 
forward TTC TGC AGG GCT CCA ATG AT 
reverse TCG ACA AGA ACA GTG TAA GTG AAC CT 
aSMA 
forward AGA GCG CAA ATA CTC CGT CT 
reverse CCT GTT TGC TGA TCC ACA TC 
IL-17a 
forward ATC TGT GTC ACT GCT GCT G 
reverse GAG TCC AAG GTG AAG TAG ATC G 
IL-23a 
forward GAG GGA GAT GAA GAG ACT ACC A 
reverse CAG GCA GAA CTG AGT GTT GT 
internal ref-
erence b-actin 
forward GCT ATT TGG CGC TGG ACT T 
reverse GCG GCT CGT AGC TCT TCT C 
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5.2.11. Histology and immunohistochemistry (IHC) 
Cornea samples in vivo were processed for histology and IHC as previously described (21). 
Briefly, samples were fixed in 4% PFA, dehydrated, embedded in paraffin (Tissue-Tek, 
Sakura Finetek, Torrance, CA) and sectioned at 5 µm thickness. Hematoxylin & Eosin 
(H&E; Sigma-Aldrich) staining was carried out per the protocol to examine corneal stromal 
and epithelial reconstruction. IHC (fluorescence) was performed to visualized the expres-
sion of wound healing related markers. Primary anti-CD11b antibody was purchased from 
BD Biosciences (BDB550282) and anti-alpha smooth muscle actin (aSMA) antibody was 
from Dako (Clone 1A4). Goat anti-mouse and anti-rat antibodies (conjugated with Alexa 
Fluor 594; Thermo Fisher Scientific) were used as secondary antibodies. The sections were 
either imaged with Axio Imager 2 or confocal laser scanning microscope (LSM 510; Carl 
Zeiss). 
5.2.12. Statistical analysis 
Data are expressed as mean values ± standard deviation, and quantitative experiments were 
performed with at least triplicates. Significance was analyzed by one-way analysis variance 
(ANOVA). Statistical comparisons were between IL-1b stimulated group and each dECM 





5.3.1. The processing and morphology of particulate ECMs 
Three different porcine tissues: lymph nodes (LN), cartilage (CA) and cornea (CO) (Figure 
5.1A), were processed. As shown in the schematic, tissues were first decellularized to re-
move cellular components, and particulate ECM scaffolds were obtained by cryogenic pul-
verization. The morphology of the ECM particles was revealed by SEM imaging (Figure 
5.1B). After processing, the ECM of lymph nodes mostly formed spherical particles. Car-
tilage ECM also formed some spherical particles, but it had elongated fibers and porous 
particles as well. While instead of separate spherical particles, cornea ECM formed micro-
scopic lamellar sheets with fibrillar structures. 
Similarly, the difference of particulate ECMs originated from various sources is also re-
flected on size distribution (Figure 5.1B). LN-ECM has a broad distribution that ranges 
from 68.06 to 6439 nm, with an average of 1502.3 nm. CA-ECM has a relatively narrower 
range, which is between 825 and 6439 nm, and the average is 2967.9 nm, the biggest par-
ticle size among all three. CO-ECM has a discontinuous distribution, and a much smaller 





Figure 5.1. ECM processing and characterization. 
(A) Porcine native tissues (lymph nodes, cartilage and cornea) were decellularized and pulverized 
into ECM particles. (B) SEM images and size distribution of ECM particles from different tissue 







5.3.2. The anti-inflammatory effect of ECM particles on keratocytes in vitro 
Three types of ocular surface cells were isolated from rabbit tissues, including CECs, 
LGACs and corneal keratocytes. They were used for the study of the anti-inflammatory 
effect of ECM particles in vitro (Figure 5.2A). After keratocytes were exposed to IL-1b, 
inflammatory genes tumor necrosis factor alpha (TNFa), IL-6 and matrix metalloprotein-
ase 9 (MMP9) all had drastic increase in mRNA level (Figure 5.2B). LN- and CO-ECM 
significantly decreased TNFa expression and CA-ECM reduced IL-6 expression. All three 
types of particulate ECMs lowered MMP9 expression, but it was still significantly higher 
than the level of control. Inflammatory environment and ECM supplements also have in-
fluence over the morphology of keratocytes in vitro as revealed by F-actin staining (Figure 
5.2B). Under normal condition (control), keratocytes had a stellate shape with multiple 
processes (Figure 5.2B arrowheads). The keratocytes became more spread out with very 
few processes when IL-1b was present. Particulate ECMs increased the number of pro-





Figure 5.2. The anti-inflammatory effect of dECM on ocular surface epithelial cells in vitro. 
(A) Ocular surface cells (lacrimal gland acinar cells, corneal keratocytes and conjunctival epithelial 
cells) were isolated and subject to IL-1b stimulation and ECM treatment. (B) Changes in gene 
expression (RT-qPCR) and morphology of keratocytes (F-acin staining) after exposure to IL-1b 
and ECM particles. F-actin was stained by phalloidin (green); cell processes were indicated with 
arrowheads. Scale bar: 50 µm. (C) RT-qPCR of tear film related gene expression of conjunctival 
epithelial and lacrimal gland acinar cells. (D) Mucin layer secreted by conjunctival epithelial cells 
in air-lifting culture was imaged by confocal microscope stained with Texas Red conjugated dex-
tran. Images shown here were constructed from the x-z plane of a series of z-stacking images. Scale 
bar: 100 µm. Thickness values were measured from corresponding mucin layer images by Pho-




5.3.3. The influence of ECM particles on tear secretion of ocular surface cells 
in vitro 
Gene and protein expressions related to tear secretion were examined for the in vitro ex-
periments with CECs and LGACs, the two main components responsible for tear secretion. 
We found that IL-1b stimulation did not influence the level of mucin (MUC1) or mucin 
5AC (MUC5AC), membrane bound mucin and secreted gel-forming mucin from the con-
junctiva, respectively. However, the addition of LN-ECM increased MUC5AC expression 
by more than 2 folds. Regarding lacrimal gland related genes, inflammation environment 
resulted in fewer aquaporin 5 (AQP5) mRNA, and LN- and CO-ECM were able to restore 
the level back to normal. Lactotransferrin (LTF) mRNA was increased significantly when 
inflammation was induced by IL-1b, and ECM increased it even further (Figure 5.2C).  The 
actual mucin film secreted by conjunctival goblet cells was stained with Texas Red conju-
gated dextran and imaged using confocal microscope with z-scanning, and the thickness 
was analyzed (Figure 5.2D). Texas Red-dextran has a good quantum yield and is relatively 
impermeable across the epithelia. Inflammation caused the mucin film thickness changed 
from about 30 µm to 20 µm, a much thinner layer as viewed under confocal microscope. 
When ECM particles were added to the medium, conjunctival goblet cells were able to 
secret more mucins even in an inflammatory environment. 
Inflammatory gene expression and lysozyme (NAG) secretion were also examined for 
CECs and LGACs. In both type of cells, the stimulation of IL-1b induced significant in-
crease the gene expression of multiple proinflammatory cytokines and chemokines, such 
as TNFa, IL-6, IL-8 and MMP9 (Figure 5.3A,B). The addition of LN-ECM was able to 
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reduce the expression of certain genes (IL-8 and MMP9 of CECs and MMP9 of LGACs, 
respectively), but the levels were still higher than control, and this effect on other genes 
was insignificant. The other two type of particulate ECMs, cartilage and cornea, had no 
significant influence on inflammatory gene expression. The NAG activity stimulated with 
carbachol is an easily measured function of LGACs (b-hexosaminidase assay). NAG se-
cretion was slightly increased when IL-1b was added, and CA- and CO-dECM did not alter 





Figure 5.3. The anti-inflammatory effect of ECM on conjunctival epithelial and lacrimal gland acinar cells in vitro. 
(A,B) RT-qPCR results of inflammatory gene expression of conjunctival epithelial and lacrimal gland acinar cells. (C) Lacrimal gland secretion 
measured by b-hexosaminidase assay for lysozyme (NAG). *p < 0.05; **p < 0.001. 
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5.3.4. ECM particle transplantation after SLK surgery 
Because of its anti-inflammatory ability, LN-ECM particles were selected as the most po-
tent one to be used in the application in vivo. SLK surgery (6.0 mm diameter and 100 µm 
depth) was performed with automated microkeratome and the flap was removed afterwards. 
About 20 µL of FG was applied on the wound as a positive control. ECM was mixed with 
FG during application. Outcomes from four groups (control, untreated, FG and FG+ECM) 
were compared (Figure 5.4A). The epithelialization of cornea after SLK was assessed by 
fluorescein staining (Figure 5.5). The healing process was completed in all three groups by 
day five, shown with no visible fluorescein staining. The re-epithelialization of the two 
treated groups (FG and FG+ECM) was slightly behind the untreated group at day two and 
three (Figure 5.5A,C). Slit lamp examination with diffused or focal illumination (Figure 
5.4B,C) revealed that severe scar formed in untreated group after SLK. While there was 
some cornea haze developed in the two treated groups (FG and FG+ECM) at week one, 
the scar was significantly reduced and invisible at week four. Corneal haze after SLK was 
quantified at day 7, 14 and 28 (Figure 5.5B). The image was adjusted to gray scale, and the 
value of haze was expressed as integrated intensity of the area within the dashed line (Fig-
ure 5.5B insert). Without treatment, corneal haze kept increasing during the whole course 
of study. At week two and four, corneas treated with FG and/or ECM drastically reduced 
haze compared to the untreated group. Furthermore, at all three time points, FG+ECM re-





Figure 5.4. In vivo application of ECM particles on cornea after lamellar keratectomy. 
(A) Surgery procedures. The flap was removed, and in the untreated group, corneal stroma was left exposed; FG sealant with or without ECM was 
applied on the wound. ECM particles were visible within the FG gel. Rabbit corneas examined at different stages by slit lamp using direct diffuse 
(B) and focal/beam (C) illumination. 
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The reduction in scar tissue and corneal opacity was also revealed by in vivo confocal im-
aging (Figure 5.6). Keratocytes in healthy cornea were clearly visible in all three parts of 
the stroma. SLK surgery without treatment resulted in severe scars (bright with high inten-
sity) in anterior to mid stromal tissue at both one- and four-week time points. FG treatment 
alone reduced the amount of scar within the cornea at week four. However, there was still 
some scar tissue retained in the anterior part of the stroma. LN-ECM treated cornea only 




Figure 5.5. Corneal re-epithelialization and corneal haze in different groups after SLK. 
(A) Re-epithelialization quantified from fluorescein staining images in (C) at different time points. 
Stained area (green) indicated injured cornea that is not fully covered by epithelium. Data was 
presented as percent stained with fluorescein, normalized to area of the whole cornea. (B) Corneal 
haze quantification. Images from (Figure 5.4B) were switched to gray scale and the background 
was adjusted too for consistence among groups. The dashed circle is right above the pupil and was 
analyzed for haze area and intensity (black and white insert). The “integrated intensity” value ob-







Figure 5.6. Corneal stromal tissue imaged by in vivo confocal microscope. 
In control group, keratocytes were clearly imaged in all layers (anterior, mid and posterior) of 
stroma. High intensity (brighter) indicated the presence of scar tissue within the stroma. Images 





5.3.5. The immunoregulatory effect of ECM particles on corneal wound heal-
ing after SLK 
The immunoregulatory effect of ECM particles was investigated throughout the animal 
study.  Gene expression of proinflammatory cytokine TNFa was downregulated at both 
day 7 and 28 by FG and/or ECM treatment (Figure 5.7A). FG’s reduction effect on the 
mRNA level of MMP9 was only significant at the later time point (day 28). FG+ECM 
decreased MMP9 expression at both time points. FG+ECM treatment also suppressed 
iNOS expression at week one, and arg1 was upregulated in all surgical groups at week one. 
By week four, iNOS expression in FG and/or ECM treated groups were higher than healthy 
and untreated corneas. However, arg1 expression went down in most groups except in FG 
treated cornea (Figure 5.7B). 
Immunohistochemistry with CD11b showed macrophage/monocyte infiltration at early 
stage (one week) during the wound healing process (Figure 5.7C). We observed a signifi-
cant amount of migrated immune cells in the wounded stromal area in the untreated group. 
There were fewer CD11b+ in FG treated group, and even fewer cells when ECM was added 
along with FG. Staining of Ki67 (Figure 5.7D), the marker for cell proliferation, demon-
strated that at early time point (one week), SLK led to the proliferation of epithelial and 
stromal cells. Corneal cells stayed quiescent at four-week time point, and only a few epi-





Figure 5.7. The anti-inflammatory effect of ECM on corneal wound healing in vivo. 
(A,B) Inflammatory gene expression (TNFa, MMP9, iNOS and Arg1) of reconstructed cornea at 
day 7 and 28 in different groups, measured by RT-qPCR. (C) CD11b immunostaining (red) show-
ing myeloid cell infiltration in the wounded area at week one. Scale bar: 200 µm. (D) Ki67 staining 
showing the presence of proliferating cells within the healing corneas at both week one and week 




5.3.6. ECM influenced corneal fibrosis during wound healing 
Markers associated with fibrosis were examined at week four during the wound healing 
exp. A decrease in the gene expression of TGFb1, connective tissue growth factor (CTGF), 
Type I collagen (COL1) and aSMA was observed resulted from FG and/or ECM treatment, 
and FG+ECM’s effect was more prominent than FG alone (Figure 5.8A). IL-17a was 
downregulated by FG and/or ECM treatments at week one, and its expression went down 
to the level of control at week four. FG and/or ECM treatments also increased IL-23a ex-
pression at early time point, but FG alone continued to upregulated IL-23a till week four 
(Figure 5.8B). 
H&E staining was used to assess the fibrotic tissue within corneal stroma (Figure 5.8C; 
arrowhead). Dense fibrotic tissue formed in the stroma underneath the epithelium in the 
untreated group. FG treatment significantly reduced the severity of fibrosis. However, fi-
brotic tissue was reduced to minimum within corneal stroma in FG+ECM treated group. 
The addition of LN-ECM particles also affected the morphology of reconstructed corneal 
epithelium. Epithelial hyperplasia (thickened epithelium) was observed in untreated and 
FG-treated group, but absent in the FG+ECM treated group (Figure 5.8C; arrow). Im-
munostaining with aSMA at week four illustrated similar result (Figure 5.8D). Within the 
stroma of untreated cornea, large area was stained positive with aSMA, a marker for my-
ofibroblasts. After FG treatment, the aSMA+ area was reduced within anterior stroma, and 




Figure 5.8. The anti-fibrotic feature of ECM on corneal wound healing in vivo. 
(A,B) The expression of genes related to fibrosis (TGFb1, CTGF, COL1, aSMA, IL-17a and IL-23a) was quantified by RT-qPCR at both week one 
and week four. (C) H&E staining of reconstructed corneal stroma and epithelium after SLK. Arrowheads are showing stromal scars formed after the 
surgery. The arrow indicated possible epithelial hyperplasia (thickening). Scale bar: 100 µm. (D) aSMA immunostaining (red) showing fibrotic 
tissue in the reconstructed corneal stroma at week 4. Scale bar: 50 µm. *p < 0.05; **p < 0.001. 
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5.4. DISCUSSION 
Biomaterial derived from decellularized tissue ECM have been extensively studied and 
successfully applied in regenerative medicine for decades. As scaffolds for tissue repair, 
they offer many mechanical and structural advantages that are inherited from the native 
tissue. The extracellular signaling molecules and the residual intracellular content in ECM 
scaffolds also play an important role in supporting tissue remodeling and cell differentia-
tion (96). After chemical, enzymatic and mechanical processing, ECM scaffolds could still 
retain structural features of the source tissue, and this is proved in our study as well. SEM 
images of dECM particles obtained from lymph nodes, cartilage and cornea show distinct 
features in morphology, and size distribution analysis also revealed difference in average 
particle size among the three particulate ECMs (Figure 5.1). For example, the long fibrils 
are unique to CA-ECM particles, which could also explain the wide range of the particle 
sizes. CO-ECM particles mainly contain lamellae-like structures and have a discontinuous 
particle distribution, which are indicators of the lamellar stacking within corneal stroma. 
Particulate ECM materials lose the load-bearing ability, however they become more ver-
satile regarding delivery methods. They were used as media supplements in vitro and de-
livered to the ocular surface using FG sealant as a carrier. Considering the particle size (0.2 
- 3.0 µm), they could also be injected via syringe to the target sites. 
As more refractive surgeries are performed every year, corneal haze, dry eye and fibrosis 
are examples of complications that may happen after laser-assisted in situ keratomileusis 
(LASIK) and photorefractive keratectomy (PRK) surgeries. Cornea wound healing in-
cludes the crosstalk of many molecular mediators secreted by corneal and immune cells 
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(100). When the ocular surface epithelium is injured, IL-1 cytokine is released from dam-
aged epithelial cells, consequently causing inflammatory cell infiltration into the ocular 
surface area (86, 100). Excessive inflammation could lead to acute or chronic dry eye and 
even neovascularization in the reconstructed corneal stroma (100). Many patients with se-
vere cornea or ocular surface injuries often develop dry eye symptoms as well, and reduced 
level of anti-inflammatory components in the tear film could worsen the situation, making 
the wound healing process even more complicated as a vicious cycle (91, 92). Thus, the 
homeostasis of the entire ocular surface is crucial for optimal corneal wound healing. Ef-
fective regulation of the immunity within the wounded area as well as the other parts of the 
ocular surface is necessary for proper corneal wound healing and the prevention of fibrosis. 
We first screened three kinds of ECM particles in vitro, regarding their anti-inflammatory 
ability for the ocular surface. Multiple ocular surface cells were used, which are CECs, 
LGACs, and corneal keratocytes. Goblet cells (included in CEC population) and LGACs 
are the major cell types for aqueous tear secretion. IL-1b, the proinflammatory cytokine, 
was used to induce inflammation. ECM particles, especially LN-ECM, significantly re-
duced the expression of proinflammatory mediators (TNFa, IL-6 and IL-8), and proteinase 
MMP9, one of the major indicators for the diagnosis of dry eye disease (86) (Figure 5.2B; 
Figure 5.3A,B). LN-ECM also affected the morphology and functions of ocular surface 
cells cultured in vitro. It prevented the morphological change of keratocytes from stellate 
shape (quiescent stage) to elongated shape (fibroblasts and myofibroblasts) (101) (Figure 
5.2B). Furthermore, ECM particles are necessary in maintaining the normal secretion func-
tion of ocular surface cells under inflammatory conditions in vitro, regarding mucin and 
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lysozyme secretion, by goblet cells and LG acinar cells, respectively (Figure 5.2C,D; Fig-
ure 5.3C). 
The different outcomes observed from the scaffolds are possibly due to the variation in 
ECM composition of the native tissues. Lymph nodes are filled with reticular networks that 
contains fibrillar collagens and basement membranes (102). As basement membrane com-
ponents are beneficial for the growth and differentiation of epithelial cells, this could ex-
plain its effectiveness in regulating the inflammation in ocular surface epithelia. Cartilage 
and cornea are load bearing tissues, and their ECMs are composed of structural collagens 
in general (85). Therefore, despite the beneficial effects they offer to keratocytes, CA- and 
CO-ECM did not provide significant advantages as supplements for epithelial cells (CECs 
and LGACs) under inflammatory condition in vitro. 
The experiments in vitro proved that LN-ECM was the most efficient in the regulation of 
ocular surface homeostasis. Therefore, it was delivered to wounded corneal stroma within 
FG sealant. FG itself has been used frequently before as a sealant or wound dressing during 
corneal surgeries (103). The corneal epithelial healing was more or less the same among 
all three group, which is completed at day five (Figure 5.5C). The value of corneal haze 
within the reconstructed stroma proved the efficacy of FG+ECM application (Figure 
5.4B,C; Figure 5.5). It prevented the development of haze at early time point, and this effect 
persisted until the end of the study, and FG+ECM eliminated corneal haze even more than 
FG alone. 
ECM/FG application ameliorated the immune response in cornea stroma after SLK surgery, 
which is comparable to the outcomes of previous cell therapies. Subconjunctival-injected 
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mesenchymal stem cells (MSCs) exerted anti-inflammatory mechanism during the acute 
phase of corneal chemical burn (94), such as reduction of TNFa expression and infiltrated 
inflammatory cells, and the paracrine effect of MSCs could also bring down the level 
MMPs after tissue injuries (104). These effects are similar to the results we observed in the 
early stage of corneal wound healing when LN-ECM was applied. Gene expression results 
showed that proinflammatory cytokine TNFa was downregulated at both early and late 
time points. MMP9, responsible for the degradation of ECM during corneal stromal 
remolding and the immune cell infiltration later on (100), was significantly reduced in the 
two treated groups, especially when LN-ECM was applied alongside FG (Figure 5.7A). 
LN-ECM also decreased the expression of IL-23a (Figure 5.8B) and Arg1 (Figure 5.7B). 
Consequently, the number of infiltrated CD11b+ cells was scarce in the reconstructed 
stroma in the LN-ECM treated group (Figure 5.7C). The resemblance of the anti-inflam-
matory effect could possibly due to the similarity between components in LN-ECM and 
paracrine factors secreted by MSCs. Unlike cell therapies, particulate ECM are more abun-
dant, and can be prepared in advanced and stored for a long time before application. Hence 
ECM particles can be translated clinically with less complications. 
Corneal epithelial wound healing is supported by the proliferation and migration of limbal 
stem cells residing in the corneoscleral junction (105), while corneal stroma healing is a 
more complicated process. The main signaling molecules involved are the TGF-b system. 
TGF-b1 induces the transition of keratocytes to fibroblasts, the emergence of myofibro-
blasts, and consequently scar formation and wound contracture. Suppressing the expression 
of profibrotic TGF-b growth factors has been a target for reducing corneal fibrosis and 
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haze. Gene therapy that declines TGF-b1 transcription and TGF-b inhibitors such as rosig-
litazone and ROCK inhibitor are proved to be promising in managing corneal fibrosis (98, 
100). In our study, at four-week time point, TGF-b1 was highly upregulated due to corneal 
epithelial and stromal injuries. LN-ECM particles reduced the gene expression of TGF-b1, 
as well as downstream corneal scar molecules, including CTGF, COL1 and a-SMA, and 
its effect is superior to the carrier FG sealant alone (Figure 5.8A). Therefore, the anti-fi-
brotic effect of LN-ECM in reducing scar formation is possibly acted upon the TGF-b 
system as well. 
There is interaction between the epithelium and stroma while corneal wound healing is 
taking place. Injured epithelium could also secret TGF-b that induces the synthesis of ir-
regular collagen fibrils and stromal haze. Therefore, optimal re-epithelialization could 
guarantee a better stromal remodeling. Biomaterial scaffolds with basement membrane 
compositions could be effective when used for corneal epithelial healing and stromal re-
modeling, such as amniotic membrane (AM), which induced faster epithelial healing and 
less keratocytes apoptosis (106). Similarly, LN-ECM/FG gel containing basement mem-
brane components formed a barrier above the remodeling stroma, and prevented excessive 
infiltration of inflammatory cells, and eventually promoted the proper synthesis and as-
sembly of collagen fibrils, and prevented corneal epithelial hyperplasia (Figure 5.8C,D). 
Our previous study has shown that ECM scaffolds from various sources can be screened 
in vitro, and many of them have unique functions, such as guiding cell differentiation and 
inducing tissue matrix production (96). In this study, LN-ECM significantly ameliorated 
inflammation in the ocular surface both in vitro and in vivo, and reduced scar formation 
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after SLK surgery in the rabbit model. These benefits offered by LN-ECM resembles the 
paracrine effects observed from MSC therapy, and the mechanism is possibly the unique 
components originates from the lymph node reticular meshwork. Further proteomic anal-
ysis would be necessary for exact mechanism and for identifying the key signaling mole-
cules. Besides ophthalmic application, LN-ECM particles could be utilized in other sys-
tems where both inflammation control and proper ECM remodeling are needed. At the 
same time, other types of ECM materials with similar compositions could be further ex-
plored as well. To improve the therapeutic outcomes of ECM scaffolds and delay degrada-
tion, particles could be loaded in the carrier at a higher concentration, applied as a com-




In summary, particulate ECM from lymph nodes, cartilage and cornea were processed into 
micro-particles and their anti-inflammatory function on the ocular surface was assessed. 
LN-ECM, the most potent scaffold was further examined in a corneal wound healing model. 
It successfully tuned down the inflammatory response in the reconstructed stromal area 
and prevented the formation of scar tissue and corneal haze. LN-ECM is proved to be ef-
ficient in mediating the homeostasis of cornea, as well as other parts of the ocular surface. 
Tissue derived ECM scaffolds are effective and accessible therapeutics for the management 
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of corneal reconstruction after traumatic injuries to the ocular surface and refractive sur-
geries. Overall, ECM scaffolds represent a new promising alternative for the modulating 
of immune response as well as matrix remodeling during the wound healing process.	  
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Chapter 6. Summary and Future Research Directions 
 
 
The main goal of this dissertation is to utilize several approaches, including biomaterials 
engineering, model system development and novel therapeutics, to optimize wound healing 
and prevent disease progression on the ocular surface (Figure 6.1). First, we discovered 
collagen vitrigel (CV) as an alternative graft material for conjunctival wound closure, 
which also supported goblet cell repopulation and possibly decreased the occurrence of dry 
eye disease. Next, we focused on dry eye disease, and developed a model system of the 
ocular surface in vitro for pathogenesis study and drug evaluation. Particulate ECM was 
studied as a new form of therapeutics for the reduction of inflammation and fibrosis during 
corneal wound healing. These three strategies targeted concerns on the ocular surface from 
different perspectives. In the future, each strategy presented here could be further investi-
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6.1. CV AND PARTICULATE ECM FOR THE TREATMENT OF 
PTERYGIUM 
In Chapter 3, we demonstrated that CV supported the growth of conjunctival cell and re-
construction of ocular surface defects (21). Previous study has shown that CV is an excel-
lent substitute for engineering the cornea as well (31). Besides serving as a simple wound 
dressing, CV could also be used on other ocular surface diseases involving more compli-
cations. 
Pterygium is the outgrowth of noncancerous conjunctival tissue onto the cornea, resulting 
in discomfort, decreased and obstructed vision, with a high recurrence rate (107). Graft 
transplantations with adjuvants have been shown to effectively reduce recurrence rate and 
complications after excision surgeries (107-109). CV as a biocompatible material supports 
both conjunctival and corneal cells. We have shown in Chapter 3 that conjunctival equiv-
alent engineered with CV successfully repaired critical-sized defect. Therefore, CV is a 
promising candidate for wound closure after the excision of pterygia, which offers more 
advantages than amniotic membranes and other available materials as discussed in Chapter 
2. 
Over-proliferation of fibroblasts is associated with the recurrence of pterygium (110). 
Therefore, therapeutics that inhibit fibrosis and promote wound healing can be potentially 
beneficial after excision. Based on the results in Chapter 5, ECM particles significantly 
reduced inflammation and scar tissue. Thus, incorporating ECM materials together with 
CV for the treatment of pterygium could lower the reoccurrence rate even more. Similarly, 
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ECM particles can be mixed with fibrin glue sealant for the attachment of CV during ap-
plication. 
 
6.2. MICROFABRICATION OF THE OCULAR SURFACE MODEL SYSTEM 
We developed the in vitro model system for the ocular surface in Chapter 4. The model 
system recapitulates the tear secretory function of a healthy ocular surface, and it can also 
be induced as a dry eye disease model for therapeutic evaluation. To improve the organi-
zation of the model system, and make it more tunable and efficient for high-throughput 
screening, techniques such as microfabrication and microfluidics can be applied to generate 
miniaturized versions of ocular surface model systems. 
Organs-on-chips are microengineered systems which adapt microfabrication technique and 
mimic the physiological function on the organ level (35). Similarly, instead of Transwell 
insert, our ocular surface model system could be built on poly(dimethylsiloxane) (PDMS) 
chambers with microfluidic channels. Besides using proinflammatory cytokines, dry eye 
disease can also be induced by exposing the culture to desiccating stress, which could be 
more easily realized with PDMS chambers. CV could replace the porous membrane on the 
Transwell insert, for better ocular cell growth and differentiation. For the evaluation of 
multiple therapeutics, organ-on-chip systems can be linked together and the efficiency 
could be easily controlled and improved. 
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6.3. COMBINING CV AND ECM PARTICLES AS A NEW DELIVERY 
METHOD 
Particulate ECM has shown promising results in reducing the inflammation and fibrosis 
associated with corneal wound healing in Chapter 5. To increase the initial loading dose of 
ECM particles and prolong the degradation time, several approaches could be studied in 
the future. CV could replace fibrin glue sealant or be applied additionally after corneal 
injuries. ECM particles could be combined with CV during the vitrification process. 
Thicker CV can be manufactured and several sheets of CV can be stacked together to im-
prove the mechanical strength of the material composite. Particulate ECM can also be in-
jected near the injury site. For ocular surface applications, subconjunctival injection of 
ECM particles may provide extra benefit in regulating the immune populations migrating 
towards the cornea through the conjunctival lymphatics, and is also a common procedure 
in the clinic. The degradation rate of ECM particles in the new material carrier must be 
investigated to match the progress of wound healing in the cornea, as materials that degrade 
too slowly and do not integrate well with the host tissue may cause delay in re-epitheliali-
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